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Dicarboxylic acids (DCAs) are derivatives of fatty acids and can be used as precursors 
for non-petrol-based polyesters and coatings, greases, adhesives, pharmaceuticals etc. 
Short chain diacids can besynthesized in high yields whereas long chain diacids produc-
tion is tough and expensive because of its purification from their byproducts are in high 
demand.To obtain sustainable industry yeasts are considered as best example for produc-
ing diacids as they naturally produce small amount of diacids. Alkane assimilating path-
way in yeast can produce DCA by using ω-oxidation pathway but the problem is that the 
produced diacids can be catabolized in ß oxidation pathway. In the previous studies car-
ried out at VTT the yeasts Yarrowia lipolytica and Pichia guilliermondii which were 
identified as promising hosts for long chain dicarboxylic acid production were modified 
by deleting MFE2gene of β-oxidation pathway. Prior these strains can be modified further 
for example by expressing the omega-oxidation cytochrome P450 hydroxylase complex 
the marker cassettes have to be removed. To this purposes Cre-recombinase/loxP recom-
bination system was generated in this thesis. 
 
 A Cre-recombinase plasmid having Cre recombinase, Hph marker gene and au-
tonomously replicating sequence (ARS) was constructed for Yarrowia lipolytica. ARS 
sequence cloned in this thesis work was compared with published sequences and it was 
similar toYarrowia lipolytica ARS18 with 99.69% similarity.This shows the ARS se-
quence obtained in this work is equal to ARS18. 
 
Cre-recombinase plasmid was tested in MFE2 deleted Yarrowia lipolytica strain 
and it was able to loop out nourseothricin marker from genomic DNA. Additionally, Cre-
recombinase plasmid could be looped out fromYarrowia lipolytica strain. Overexpression 
of the first enzymes of ω-oxidation-(Nicotiana Tabacum P450 hydrolase and Arabidopsis 
thaliana P450 reductase) in the Yarrowia lipolytica MFE2 deleted strain was successful. 
Cultivations with 0.3 % pelagronic acid (C9 fatty acid) resulted in 78,29 mg/l of C9 diacid 
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production. Whereas with 1% oleic acid (C18:1 fatty acid) only substrate consumption 
was observed without diacid production. 
 
With Pichia guilliermondiia new method called Gibson assembly was used to 
construct the cre-recombinase plasmid. Unfortunately, only Hph marker and ARS se-
quence was cloned into plasmid.ARS sequence cloned in this work was compared to pub-
lished sequence by using Clustal-w tool: 99.76 % similarity to the existing P. guillier-
mondii ARS sequence could be detected. Work can continue further by cloning cre-re-
combinase into existing plasmid and testing the plasmid in P. guilliermondii MFE2 dele-
tion strains. 
iv 
 
PREFACE 
 
 
This work was done in Metabolic Engineering group at Technical Research Centre of 
Finland (VTT), Espoo.I would like to thank Team Leader Dr.Laura Ruohonen for giving 
me such a great opportunity to carry out my thesis in VTT. 
I would like to thank my supervisors Dr.Kari Koivuranta and PhD Eija Rintala who 
helped me in encouraging and supervision. A great help in practical work and in learning 
new techniques at VTT.My sincere gratitude to all the people working in laboratory for 
helping me in turn of my thesis. Finally, I would like to thank my family members for 
being all the time with me. 
 
Kundana Kancherla 
 
 
 
v 
 
LIST OF TERMS AND ABBREVIATIONS 
 
ACS    ARS consensus sequences 
ADP    adenosine Di phosphate  
ARS   Autonomously replicating sequences 
ATP    Adenosine Triphosphate  
ß oxidation  Beta Oxidation 
CEN   Centromere 
Cre   Cre recombinase plasmid 
DCA   Dicarboxylic acid 
DNA    Deoxyribonucleic Acid  
dNTP    Deoxynucleotide Triphosphate 
FAA   Fatty acid Activation 
FAD    Flavin Adenine Dinucleotide  
FADH2   reduced Flavin Adenine Dinucleotide  
FAO   Fatty alcohol oxidase 
H2O2    Hydrogen Peroxide  
HCL    Hydrogen Chloride  
Hph   Hygromycin Marker 
MgCl2   Magnesium Chloride  
NAD+   Nicotinamide Adenine dinucleotide  
NADH   reduced Nicotinamide adenine dinucleotide  
ORI   Origin of Replication 
ω    Omega  
P.guilliermondii Pichia guilliermondi 
S.cerviciae   Saccharomyces cerevisiae  
SDS    Sodium Dodecyl Sulphate Gel Electrophoresis   
SSB   Single strand DNA binding proteins 
Y.lipolytica  Yarrowia lipolytica 
  
vi 
 
TABLE OF CONTENTS 
ABSTRACT ...................................................................................................................... ii 
PREFACE ........................................................................................................................ iv 
LIST OF TERMS AND ABBREVIATIONS ................................................................... v 
TABLE OF CONTENTS ................................................................................................. vi 
1. INTRODUCTION .................................................................................................... 1 
2. LITERATURE REVIEW.......................................................................................... 3 
2.1 Dicarboxylic acids ............................................................................................. 3 
2.2 Beta-oxidation pathway .................................................................................... 3 
2.2.1 Peroxisomal multifunctional enzyme type 2 ....................................... 6 
2.3 ω (omega)-oxidation pathway ........................................................................... 7 
2.4 Cytochrome P-450 Monooxygenases (P450s, CYPs) ....................................... 9 
2.4.1 CYP52 Family ..................................................................................... 9 
2.5 ARS ................................................................................................................. 10 
2.5.1 Domain A ........................................................................................... 11 
2.5.2 Domain B ........................................................................................... 11 
2.5.3 Domain C ........................................................................................... 12 
2.5.4 ARS in Yarrowia lipolytica ............................................................... 12 
2.6 Yarrowia lipolytica ......................................................................................... 12 
2.7 Candidatropicalis............................................................................................. 14 
2.8 Pichia guilliermondii ....................................................................................... 14 
2.9 Industry ........................................................................................................... 15 
3. AIM ......................................................................................................................... 17 
4. MATERIALS AND METHODS ............................................................................ 18 
4.1 Yeast and bacterial strains ............................................................................... 18 
4.2 Media and growth conditions .......................................................................... 18 
4.2.1 Culture medium ................................................................................. 18 
4.2.2 TE buffer ............................................................................................ 18 
4.2.3 STET buffer ....................................................................................... 18 
4.3 Genomic DNA isolation .................................................................................. 18 
4.4 Plasmids and deletion/expression cassettes for Yarrowia lipolytica............... 19 
4.4.1 ARS plasmids for Yarrowia lipolytica............................................... 19 
4.4.2 CRE cassettes ..................................................................................... 21 
4.4.3 HPH cassettes .................................................................................... 22 
4.5 Nicotiana Tabacum P-450 hydroxylase and Arabidopsis thaliana 
P450reductase ......................................................................................................... 23 
4.6 Transformations .............................................................................................. 26 
4.6.1 E. Coli transformation........................................................................ 26 
4.7 STET ............................................................................................................... 27 
vii 
 
4.8 Yarrowia lipolytica transformation ................................................................. 27 
4.9 Yeast colony PCR ........................................................................................... 28 
4.10 Glycerol stock ................................................................................................. 28 
4.11 Sequencing ...................................................................................................... 28 
4.12 Cultivations ..................................................................................................... 29 
4.13 High-performance liquid chromatography (HPLC) ........................................ 29 
4.14 Gas chromatography-Mass Spectrometry (GC-MS) ....................................... 29 
4.15 Plasmids and deletion/expression cassettes for Pichia guilliermondii ............ 30 
4.15.1 ARS plasmids for Pichia guilliermondii ........................................... 30 
4.15.2 CRE cassettes for Pichia guilliermondii ........................................... 30 
4.15.3 HPH cassettes for Pichia guilliermondii ........................................... 31 
4.16 Gibson assembly ............................................................................................. 31 
5. RESULTS ............................................................................................................... 35 
5.1 Yarrowia lipolytica.......................................................................................... 35 
5.1.1 ARS-plasmid (pBC7) ......................................................................... 35 
5.1.2 CRE-plasmid (pBC5) ......................................................................... 36 
5.1.3 HPH + CRE - plasmid (pBC20) ........................................................ 36 
5.1.4 ARS+CRE+Hph -plasmid (pBC27) .................................................. 37 
5.2 Nourceothricin marker and CRE plasmidloop Out ......................................... 37 
5.2.1 PCR confirmation of the Nat marker loop out transformant ............. 38 
5.2.2 PCR confirmation of the Nicotiana Tabacum P-450 hydroxylase and 
Arabidopsis thaliana P450reductase ............................................................... 39 
5.2.3 Yarrowia lipolytica ARS ................................................................... 40 
5.3 Cultivations ..................................................................................................... 45 
5.3.1 HPLC (High Performance liquid Chromatography) .......................... 45 
5.3.2 Cultivations with pelagronic acid ...................................................... 46 
5.3.3 Cultivations with oleic acid (C18:1) .................................................. 49 
5.4 Pichia guilliermondii ...................................................................................... 51 
5.4.1 ARS plasmid (pBC8) ......................................................................... 51 
5.4.2 CRE plasmid (pBC6) ......................................................................... 51 
5.4.3 HPH + CRE plasmid .......................................................................... 52 
5.5 Gibson assembly ............................................................................................. 52 
5.5.1 ARS sequence of Pichia guillermondii .............................................. 53 
6. DISCUSSION ......................................................................................................... 56 
6.1 ARS ................................................................................................................. 56 
6.2 CRE casettes.................................................................................................... 56 
6.3 HPH casettes ................................................................................................... 56 
6.4 Gibson assembly ............................................................................................. 57 
6.5 Confirmation of the Nat marker loop out transformant .................................. 57 
6.6 Confirmation of the Nicotiana Tabacum P-450 hydroxylase and Arabidopsis 
thaliana P450 reductase. ......................................................................................... 57 
6.7 Cultivations ..................................................................................................... 57 
viii 
 
6.8 Comparision with Candia tropicalis ............................................................... 58 
7. CONCLUSIONS ..................................................................................................... 60 
8. REFERENCES ........................................................................................................ 61 
ELECTRONIC DATABASE-INFORMATION ............................................................ 67 
 
1 
 
1. INTRODUCTION 
Development of new applications from oils and fats were the important criteria to obtain 
sustainable industry. One application was to use fatty acid´derived products like dicar-
boxylic acids as they were considered as building blocks of polymer(Hufet.al, 2011).ω-
hydroxy fatty acids were valuable compounds in chemical industry and were raw materi-
als for industrial sectors (Bitto et.al, 2009).  
 
Bioplastics were the polymers that were derived from renewable biomass and they 
were biodegradable. Production of polyamides and polyester synthesis were mainly pro-
cessed via chemical synthesis.This production of polyamide and polyster through fats and 
oils was a novel technology in industrial fied. However, there had not been much devel-
opment in strains to produce di-carboxylic acids and no huge scale of manufacturing pro-
cess. (Huf et.al, 2011) There were also many uses with other diacids like the lithium salts 
of C9 acid were used as lubricants and also used as additives to antifreeze mixtures. 
Azelaic acid itself had more number of antibiotic properties, which were used in treatment 
of skin.  (Green et.al, 2000)  
 
Yarrowia lipolytica and Pichia guilliermondii are recognized as promising hosts 
for long chain dicarboxylic acid production.These yeasts can use long chain alkanes and 
fatty acids as the sole carbon sources. Degradation of alkanes and fatty acid metabolic 
pathways were studied intensively in above-mentioned yeasts. Metabolism of long chain 
fatty acids and alkanescontains import of substrates and sequential degradation with two 
pathways: ω-oxidation pathway and ß-oxidation pathway.They occur in two different lo-
cations: ω-oxidation pathway occurs in endoplasmic reticulum and ß-oxidation pathway 
takes place in peroxisomes. DCA production in yeast can be enhanced by genetic modi-
fications e.g. by blocking ß-oxidation and by enhancing ω-oxidation. (Cheng , et. al, 
2005). 
 
Cre recombinase-loxP system uses a site-specific recombinase Cre from bacteri-
ophage P1 that catalyses recombination between DNA recognition sites called loxP. This 
site had 34bp consensus sequences by two 13bp-inverted repeats, which are separated by 
8bp core sequence (Ribeiro et.al, 2007). This is a very efficient method for marker re-
moval from recombinant yeast strains. This system is widely used both in prokaryotic and 
eukaryotic organisms. The excision leaves behind a single loxP site. 
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There were no commercial vectors available for Yarrowia lipolytica and Pichia 
guilliermondii. Autonomously replicating sequences based vectors were described for 
these strains so ARS sequence are used as starting point for constructing these plasmid 
vectors. 
 
In this work a new technique called Gibson assembly had been used, this tech-
nique were developed by Dr.Daniel Gibson at J.Craig Venter Institute and this method 
had been licensed to New England’s BioLabs Inc., This technique is used mainly in as-
semblying different length DNA fragments. This technique was very easy to use and ef-
ficiently joins multiple overlapping DNA fragments in a single tube. The main principle 
of this Gibson master mix is that exonuclease creates a single stranded 3’ overhang which 
aids the annealing of fragments, polymerase fills the gaps and DNA ligase nicks the as-
sembled fragment. (Gibson, 2011, New England Biolabs, Inc.,) 
 
 The aim of this work was to construct plasmid vectors with codon optimised Cre-
recombinase genes and to test the constructed Cre-recombinase vectors by removing an-
tibiotic marker from MFE2 deletion strains.  
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2. LITERATURE REVIEW 
2.1 Dicarboxylic acids 
α-ω dicarboxylic acids were widely used as raw materials for synthesize plastics, poly-
mers, adhesives, perfumes and lubricants with high quality (Liu, et. al,2004). The major-
ity of industrial dicarboxylic acids were produced through chemical conversion. Shorter 
chain DCAs were manufactured by Pd (ΙΙ) catalyst with high pressure and temperature. 
Due to many applications of DCA products with long chain carbon length, costs were 
also increased as it was very expensive process.There are many companies involved in 
industrial production of long chain DCA byCandida tropicalisand to development of fer-
mentation processes.Because of high demand in removal of byproductsfrom long chain 
DCA products, purification was more difficult and more cost effective process. (Huf, 
et.al, 2011, Kogure, et.al, 2007). 
 
Long chain α, ω-dicarboxylic acids had been mainly produced by microbial fer-
mentation or oxidation. In 1980’s yeasts, Candida tropicalis and Candida cloacae were 
used to transform n-alkanes and fatty acids to dicarboxylic acids. However, there are 
many environmental problems raised due to commercial production of long chain α, ω- 
dicarboxylic acids. (Ngo, et.al, 2006). 
2.2 Beta-oxidation pathway 
Fatty acids were important molecules for life of a cell and they produce high yield of 
ATP, which acts as a fuel for cell, upon degradation in ß oxidation pathway (Hettema, 
and Tabak2000). The ability to take fatty acids or its derivatives up from environment 
was important when there is not available other nutrients. In presence of carbon source, 
the ability of cells to import fatty acids was advantageous as they can use existing mole-
cules than needlessly consuming energy required for biosynthesis. Fatty acid uptake 
mechanism in eukaryotes was not well understood but there was an evidence that fatty 
acid transport was protein dependent and saturable process for long chain fatty acids and 
this proposed other model in prokaryotes that membrane bound transporter protein was 
responsible for uptake of exogenous fatty acids. In yeast, the fatty acid metabolism was 
confined to single organelle that was peroxisomal ß-oxidation process that helped to turn 
out yeast into an attractive model organism to study about degradation of fatty acids. 
(Hiltunen, et.al, 2003) 
 
In yeast cellular fatty acid was fed by long chain fatty acyl CoA that were formed 
by two enzyme systems: fatty acid synthetase (FAS) and acetyl-CoA carbox-
ylase(Acc1p). Secondly mobilisation of stored fatty acids from lipids. Thirdly uptake of 
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exogenous fatty acids. The synthesis of free fatty acids yields acyl-CoA esters which were 
further activated by mobilisation. These acyl-CoA esters can be utilises in lipid synthesis, 
protein acylation or fatty acid permeation. Two different classes of proteins were ob-
served to stimulate the uptake of fatty acids. First class proteins contains fatty acids with 
high affinity and acts as both intracellular or extracellular fatty acid receptors.The other 
class of proteins are acyl Co-A synthetaseswhich severely effects the uptake of fatty acid. 
A novel protein named fatty acid transport protein (FATP) and fatty acyl CoA synthetases 
(FACS) increased the uptake of long chain fatty acid. ∆fat1p cells in a fatty acid metabo-
lising process resulted decrease of uptake fatty acid. (Hettema, and Tabak, 2000) 
 
Long chain fatty acids were transported as CoA esters into peroxisomes through 
peroxisomal membrane via Pxa1p and Pxa2p (Pat1p and Pat2p) transporters that belong 
to ABC transporters (Hiltunen, et. al, 2003). The mechanism of fatty acid transport across 
the membrane by transporters Pxa1p-Pxa2p is unclear but it is premised that CoA polar 
group activated fatty acid was transferred across the peroxisomal membrane by Pxa1p-
Pxa2p in ATP dependent manner (Hettema and Tabak, 2000). 
 
Figure 1: The above figure explains functions of ANT and PXAp (Theodouloua, et. al, 
.2006). 
 
According to Hettema et.al, (1996) medium chain fatty acids enter peroxisomes 
as free fatty acids, which were then activated by fatty acid activator Faa2p. In his study-
inΔfaa2p strain ß-oxidation of medium chain fatty acids was destroyed.These shows that 
faa2p has a role in the activation of MCFA’s. But there was still an unclear mechanism 
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that how MCFAs cross the peroxisomal membrane itself ?It can be either by passive flip 
flop from cytoplasmic leaflet of membrane or by protein-mediated process.  
 
 
Figure 2.The above figure shows the two separate pathways  that are involved in the 
degradation of LCFAs and MCFAs in peroxisomal fatty acid ß oxidation.(Hettema, and 
Tabak, 1996) 
 
Peroxisomal beta-oxidation pathway contains four steps: 1.Dehydration 2.Hydra-
tion 3.Dehydration and 4.Thiolytic cleavage (Poian et.al, 2012). Fatty acids were catabo-
lised and 2carbons shortened acyl Co-A and acetyl CoA were formed.Fatty acid activa-
tion to CoA-esters was essential to enter into beta-oxidation pathway (see below). (Roer-
mund, et. al, 2003) 
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Figure 3. Reactions involved in beta-oxidation pathway in peroxisomes. (Poian, et.al, 
2010. 
 
The enzymes involved in beta-oxidation were Pox1p/Fox1p, Mfe2p/Fox2p and 
Pot1p/Fox3p. The ß-oxidation process starts with oxidation of acyl-CoA substrate into 
trans-enoyl-CoA by FAD dependent enzymes acyl-CoA oxidase Pox1p/Fox1p. 
Pox1p/Fox1p passes the electrons directly to oxygen to generate H2O2 (Hiltunen, et.al, 
2003).In Yarrowia lipolyticathere areseveral acyl-CoA oxidase isoenzymes with different 
chain lengthspecificity (Wang, et.al., 1999(a)).  
2.2.1 Peroxisomal multifunctional enzyme type 2 
The physiological activity of this enzyme had been identified from Saccharomyces cere-
visiae.  This enzyme catalyses the dehydrogenation and hydration of trans-2-enoyl-CoA 
substrate through an R-specific pathway (Ylianttila, M. 2005). MFE-2 type proteins 
mainly present in yeast had three functional domains with one polypeptide chain (Poirier, 
et.al, 2006). 
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Multifunctional enzymes type 1 and multifunctional enzyme type 2 contain 3-hy-
droxyacyl-CoA dehydrogenase and 2-enoyl-CoA hydratase activities. The main differ-
ence between them isthat Type 1 is specific to S-isomeric substrates and type 2 was spe-
cific to R-isomers. The 3-hydroxyacyl-CoA dehydrogenaseof MFE2 had a very interest-
ing feature; it undergoes duplication and obtains two 3R-hydroxyaxyl-CoA dehydrogen-
ases in a same polypeptide chain but with different specificities of chain length. The first 
dehydrogenase A in amino terminus catalyses the reaction for long and medium chain 
substrates that are like 3R-OH-C10-(3R)-OH-C16. The second dehydrogenase B region 
sequence between hydratase 2 and dehydrogenaseAin MFE-2 shows the activity between 
3R-OH-C4. (Ylianttila, et al., 2006). 
 
Mfe2p/Fox2p dehydrogenase enzymes in mammals had been duplicated domain 
organization Domain A and Domain B, Domain B had highest activity towards short 
chain substrates and Domain A had activity towards long chain fatty acids. Inactivation 
of any domains introducing point mutations into DNA sites shows them both are active 
enzymatically (Qin, et.al, 1999,Hiltunen and Qin. 2000). The yeast hydratase enzymes 
and mammalian enzymes were related to each other in amino acid sequence but they were 
different in their kinetic activities (Jiang, et.al,1996). 
 
The last step in beta-oxidation is carried out with ketoacyl-CoA which undergoes 
thiolytic cleavage by Pot1p/Fox3p enzymes and produces acetyl-CoA and a 2 carbons 
shortened AcylCoA (Einerhand, et.al, 1991). 
2.3 ω (omega)-oxidation pathway 
Verkade and his colleagues discovered ω-Oxidation at 1932 in Netherlands by feeding 
fatty acids with different chain lengths to dogs and they observed these resulting urinary 
dicarboxylic acids (Coon, 2005). 
 
In omega-oxidationthe fatty acid was converted into dicarboxylic acid by three-
step pathway (Eirich, et. al, 2004). In the first step fatty acids were catalyzed into ω-
hydroxy fatty acids by cytochrome P450 monooxygenase and a NADPH: cytochrome 
P450 oxidoreductase complex.(Eschenfeldt,et.al, 2003). According to Scheller, et.al, 
1998 the first step in ω-oxidation pathway is only considered sure and it is performed by 
hydroxylase complex present in endoplasmic reticulum membrane and forms by P450 
monoxygenases and NADH dependent P450 reductase. ALK genes that belong to CYP52 
family code these monoxygenases. It had proved in Candida maltosa by overexpressing 
P-450 52A3. This strain had been able to perform all steps in omega oxidation to produce 
DCA. (Scheller, et.al, 1998) 
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In second step, the alcohol producedin the first step is further oxidized to an alde-
hyde by fatty alcohol oxidase (FAO). Finally, dicarboxylic acids were produced from 
fatty acid aldehyde by fatty aldehyde dehydrogenase (FAHDH). (Eirich, et.al, 2004) 
 
Figure 4.The above figure explains the terminal oxidation of alkanes and fatty acids.Di-
acids were produced through omega oxidation, which was used in alkane utilisation and 
takes place in Endoplasmic Recticulum.Whereas beta oxidation helds in peroxisomes 
(Huf, et. al, .2011). 
 
According to Eirich, et.al, 2004 Candida tropicalis strain ATCC 20336 can con-
vert fatty acids into long chain dicarboxylic acids via ω-hydroxy fatty and ω-aldehydes 
by a fatty alcohol oxidase gene (FAO). In this strain ß oxidation is blocked and three FAO 
genes have been cloned (FAO1 and FAO2a and FAO2b). Fermentations were performed 
by using High oleic sunflower fatty acid (HOSFFA) as a substrate and glucose as a cosub-
strate. There was no FAO activity for 2 to 4 hours but a rapid increase of peak had been 
seen after 30 to 40hours of post induction of HOSFFA substrate.DNA sequences of clones 
were compared topreviously cloned fatty alcohol oxidase (FAOT) and its been concluded 
that FAOT is different from FAO's sequences. Relative activities of FAOA1, FAO2a and 
FAO2b on 1-alkanols and 2-alkanols were studied by using 20mM acetone concentration. 
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An interesting result observed that FAO1 utilizes omega-hydroxy fatty acids as substrate 
and FAO2 utilizes 2-alkanols as substrate. This concludes that FAO1 is more expressed 
in fatty acid conversion to diacids. (Eirich, et.al, 2004) 
2.4 Cytochrome P-450 Monooxygenases (P450s, CYPs) 
In eukaryotes cytochrome P450s play a key role in several reactions especially in steroid 
biosynthesis that takes place either in endoplasmic reticulum or in mitochondria (Ma-
kovec and Breskvar.1998). Cytochrome P450 monoxygenases were comprised of a large 
family enzymes which function as enzyme catalysts and were mainly involved in synthe-
sis of steroids, lipids, vitamins, sterols etc., they were also involved in xenobiotic, carcin-
ogens, biotransformation of drugs and some biosynthesis of natural products(Kurtzman, 
et.al.,2011). There were 21 sequences presently belonging to CYP52 family under the 
P450 nomenclature super family, which involved in terminal oxidation of long chain n-
alkanes. Which was also the rate determining step of n-alkane degradation pathway 
(Scheller, et.al,1998). 
 
P450BM3 was a best example for redox partner enzymes where P450 enzymes were 
fusedto generate multidomain entities.P450BM3 enzymes were flavocytochrome enzymes 
formed by fusion of soluble, fatty acid hydroxylase P450 to cytochrome P450 reductase. 
These enzymes oxygenate ω1-ω3 carbons with saturated fatty acids of chain length car-
bon C12 – C18 and different polyunsaturated and saturated fatty acids. 
(Munro et.al, 2007)   
2.4.1 CYP52 Family 
The Cytochrome P52 (CYP52,P450 Alk) family was composed of many subfamilies, 
mainly they are found in n-alkane assimilating Candida species like Candida tropicalis, 
Candida lipolytica, Candida bombicola and Candida maltosa.The Alk enzymes were re-
sponsible for initial and rate-limiting step of hydroxylation of fatty acids and alkanes. 
These products were oxidized further and finally metabolized through ß-oxidation path-
way. Numerous CYP52 genes were involved in encoding isozymes, which have different 
overlapping substrate specificities. These genes were mostly inducible by exogenous like 
alkenes, n-alkanes, fatty acids and fatty alcohols of different chain length (Cresnar and 
Petric.2010). The rate-limiting step in conversion of n-alkanes to fatty acids and then to 
aliphatic diacids were carried out byCYP52 protein and hence this CYP52gene was nec-
essary to overexpress to enhance DCA production (Craftet.al, 2003). 
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Figure: 5.In this pathway it showed that α and ω diacids transportation to peroxisomes 
in the form of fatty acyl-CoA and then ß-oxidation pathway in peroxisomes. Product of 
beta-oxidation acetyl-CoA is transfered into mitochondria by carnitine-antiporter and 
became a starting product of citric acid cycle (Huf, et. al, 2011). 
2.5 ARS 
In yeast genome, there are short specific DNA sequences, with A and T rich base pairs 
know as autonomously replicating sequences. These sequences have unique ability of 
high frequency transformation and maintain stable plasmid. (Dhar, et.al, 2012) 
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Figure 6.In this figure it explained clearly about the structure of autonomously replicat-
ing sequences with different domains Domain A, Domain B (B1, B2, and B3) and Domain 
C(Dhar,et.al, 2012). 
2.5.1 Domain A 
Domain A had a sequence of 11base pairs called as ARS consensus sequence (ACS) 
[(A/T) TTTAT (A/G) TTT (A/T)]. In most of the eukaryotes, the above sequence was 
comprised with origin recognition complex (ORC) as this was a protein initiator in cells. 
(Chang, et al., 2008). ORC main function was its ability to bind DNA origin and ACS 
sequence was necessary to bind ORC-DNA binding and origin function. B elements en-
hance the function and ORC protects 50bp of DNA that contains B1 and ACS sequences. 
Binding of these two regions together known as ORC-DNA binding and as a core region 
of origin function(Lee and Bell 1997). ACS element comprises of A-T rich  consensus 
sequence and an active ARS contains 9/11 or 10/11 match sequences. ACS binds to ORC 
Origin Recognition Complex and necessary for intiation of replication. (Dhar, et.al, 2012) 
2.5.2 Domain B 
Domain B, was for the function of ARS, a 100basepairs cis acting element located to 
downstream from ACS. A mutationin this domain reduced the serenity of DNA unwind-
ing and capability of replication origin, hence, these were known as DUEs (DNA unwind-
ing elements) and no consensus sequences were found in this domain. Domain B consists 
of short sequences in its downstream and was divided in B1, B2, B3 and B4 elements. 
Element B1 had high affinity to ORC binding and its function as replicator. An ORC 
contact with DNA sequence elements and contains few elements from B1 that activates 
replication origins in S phase. Element B2 interacts with Single strand DNA binding 
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(SSB) proteins in DNA.Element B3 binds to ARS binding factor 1,this helps for cell vi-
ability in yeast and activates transcription, triggers DNA replication and silencing the 
gene. Element B4 had a capability of substituting remaining B elements. (Dhar, et al., 
2012). 
2.5.3 Domain C 
Domain C consists of 200base pairs extends to the left side of domain A. Plasmids 
were destabilize when there were deletions in elements Domain B and Domain C but it 
does not terminate replication as it happend in Domain A(Celniker et.al, 1984). 
2.5.4 ARS in Yarrowia lipolytica 
ORI – (Origin of Replication) alone cannot maintain plasmid extrachromosomally, cen-
tromeric sequence was compulsory to maintain a stable plasmid. Totally, three ARS had 
been identified for Y.lipolytica.All of them carries a centromere sequence and chromoso-
mal origin of replication: ORI3018/CEN3,ORI4002/CEN4 and ORI1068/CEN1. All the 
sequneces were able to induce LEU2 locus and CEN 1 & 3 were closely related to chro-
mosomal centromere, it also correspond to pause the polymerase site. Both CEN and ORI 
functions individual regions of ARS and can exchange between ARS and CEN. Thus 
chromosomal ORI was required for Yarrowia lipolytica ARS. Butonly two of ARS se-
quences had been confirmed: ARS18 and ARS 68. All the sequences were able to induce 
chromose breakage when they were integrated to LEU2 locus. ORI and Centromere func-
tions were carried individually by ARS inserts (Barth and Gaillardin 1997). 
 
In genome replication, origins were distributed for every 20kb to 50kb andchro-
mosomal origins near to centromere was needed for autonomous replication. Thus  a CEN 
sequence was always needed  for replication inYarrowia lipolytica (Vernis et.al. 
1998).Yarrowia lipolytica CEN derived sequences does not have indicative sequence 
similarity but shares more DNA structural motifs which includes juxtaposition of con-
served repeats and few contains dyad symmetries. The genome sequence of Yarrowia 
lipolytica centromeres had similar features present in higher eukaryotes and fungi (Ver-
nis., 2001).ARS18 and ARS68 sequences of Yarrowia lipolytica were identified as sup-
porting extra chromosomal replication with each carrying 1-kb of centromere (CEN). 
Plasmids with these ARS sequences transform with high rate of frequency and were more 
stable than any other ARS plasmids (Fournier, et al, 1993). 
2.6 Yarrowia lipolytica 
Yarrowia lipolytica was an ascomycetous yeast and originally classified as Candida lip-
olytica. In middle of sixties, it has been recognized as important industrial interest as it 
was able to use n-paraffin as a sole carbon source. These were non-conventional yeast 
species and can be isolated from dairy products. It mainly used glucose, acetate, alcohols 
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and hydrophobic substrates like alkanes and fatty acids as a carbon sources. It had 20.5Mb 
of genome, whichcontains with 49% of G+C content and made up of six chromosomes 
(Barth and Gaillardin 1997). 
 
Yarrowia lipolytica was dimorphic yeast because it either can be as a true myce-
lium or yeast-like cells based on available conditions (Casaregola et. al., 2000). They can 
be exhibit in many colony shapes glistening and smoothy kind to heavily convoluted 
form. These strains are strictly aerobic strains and most of them cannot grow above 
32°C.Hence they were not considered as pathogenic strain. Most important factor was it 
can associate with hydrophobic substrates or protenaceous. (Thevenieau,et.al, 2009). 
 
In Yarrowia lipolytica there were two long chain fatty acid synthetases: Acyl-CoA 
synthetase-Ι that was phosphatidylcholine independent and involves in cellular lipid syn-
thesis. Acyl-CoA synthetase-ΙΙ was phosphatidylcholine dependent and produces acyl-
CoA which was degraded by ß-oxidation (Mishina,et.al.,1978).This peroxisomal ACS II 
requires ATP provided by Adenine nucleotide transporter protein(Ant1p).In S. cerevisiae 
Ant1p was an integral protein of peroxisomal membrane and it was inducible by oleic 
acids.(Roermund et. al,2003,Palmier, et.al, 2001) 
 
POX genes were identified as genes that encode acyl-CoA oxidase in Yarrowia 
lipolytica.There were five POX genes identified in this Y.lipolytica whereas there exists 
only one gene in S.cerevisiae and three in Candida tropicalis. First step of β-oxidation 
pathwayis catalyzed by Acyl-CoA oxidases, that was the oxidation of acyl-CoA to trans-
enoyl-CoA. The physiological functions of these oxidase enzymes was studied by dis-
trupting genes.Acyl Coenzyme A Oxidase (Aox) isozyme activitieswere determined by 
using oleic acid and glucose as a substrate. Single null mutations did not affect much to 
growth but it affected the acyl-CoA oxidase activity.This had been the first POX disrupted 
gene in Yarrowia lipolytica. MTLY20 construct was ΔPOX2 and ΔPOX3, there were a 
defect on oleic growth plates and there were no effect with liquid YNO medium.There 
was no growth observed inMTLY37 construct and in this construct four POX genes were 
deleted ΔPOX2, ΔPOX3, ΔPOX4 and ΔPOX5 genes. After comparing all the combination 
of disruption POX genes it was concluded that POX2 and POX3 codes specific chain 
length of Aox, POX4 codes for small Aox partial growth and POX5 codes for non-spe-
cific chain length. Aox2 were more active against long chain fatty acids and Aox3 show 
active towards short chain fatty acids. This explains that lack of Aox activity and no 
growth on oleic acid can be used to study invivo import of Aox genes into peroxi-
somes.Yarrowia lipolytica had Aox isoenzymes that were more complex than in other 
yeasts and these show its ability to grow on hydrophobic substrates like fatty acids, fat 
and alkanes. (Wang, et. al, 1999(b)) 
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2.7 Candida tropicalis 
Long chain dicarboxylic acids in Candida tropicalis are produced by aerobic and viscous 
fermentation system. During this process oxygen supply had an important role. Lack of 
this supply leads to the suboptimal productivities and low quality products were pro-
duced. Therefore, limitation of oxygen supply in this system was a major problem for the 
production. Modified reactor designs, using oxygen vectors or using pure oxygen through 
gas inlet are few techniques, which had not been successful. A new method had intro-
duced to overcome the problem, namely, gas-liquid transport system. This method is not 
only to increase oxygen supply but also enhance the rate of metabolism. CT1-12 strain 
Candida tropicalis showed that adding H2O2 to the fermentation system could be con-
verted to oxygen, which is available directly from cultureand water by a catalase enzyme. 
It also increases the metabolism of cytochrome P450.High concentration of H2O2 is toxic 
to cells but low concentration increases the oxygen supply. The DCA production of 
brassylic acids increased from 16.5g/l to 22.7g/l approximately in 80hour 2mM H2O2 
concentration. (Jiao, et.al, 2001) 
 
There was a search for best yeast producer of sebacic fatty acid and brassylic acid. 
Different cultures were grown using n-alkanes like decane and tridecane as a sole carbon 
source with strains like Saccharomyces, Torulopsis, Hansenula, Yarrowia, Pichia and 
Candida. Out of 200 different cultures Candida tropicalis Tv-8 strain was choosed as a 
best strain for producing highest amount of Sebacic acid when decane was used as a car-
bon source.Tv-8 Candida tropicalis produced 4.2mg/100ml where as other strains pro-
duced <= 3mg/100ml of medium. (Ulezlo and Rogozin. 2003) 
2.8 Pichia guilliermondii 
Pichia guilliermondii, is classified as an asporogenous species, were formerly called as 
Candida guilliermondii. This species were recognised as industrial interest yeast because 
of its flavinogenic nature. P.guilliermondii is considered as model organism because of 
its high potential of converting xylose to xylitol; anti caries, sweetner.Genetics of this 
yeast species were studied primarily based on its ability to use hydrocarbons (n-hexade-
cane) as sole carbon and energy sources. It is capable of producing single cell protein 
hydrocarbons and utilizes hemi cellulosic hydrolysates obtained from acid hydrolysis. 
Ability of overproducing riboflavin during lack of iron deficient medium was a special 
feature of this strain. (Sibirny, et.al, 2009 and Boretsky, et.al.,1999) 
 
Pichia guilliermondii ARS was called as PgARS and it is located at 3' end of the 
RIBI open reading frame. This strain had similar ARS features like other yeasts with 71% 
of A+T base pairs content.PgARS were used to develop a high efficient transformation 
system. Optimal temperature for this strain is 30 °C and had an upper limit of 42 °C. 
Construction of knockout strains, selection markers, as well as ARS elements provides a 
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promising tool for developing molecular biology technical application interest in indus-
trial atmosphere. (Sibirny, et.al, 2009 and Boretsky, et.al.,1999)  
2.9 Industry 
The market value of dicarboxylic acids was very high and there were few companies, 
which were into market for production. 
Casda Biomaterials Co., Ltd. 
This plant had a history of 24years and it was a largest plant in china for producing  se-
bacic acid. It produces 23000 tons of per annum and mainly used in nylon industry. Be-
cause of its quality, it reached too many countries like US, Europe (Italy, Holland, Bel-
gium and France) and Japan.Casda Biomaterials, China.2013. 
Cathay Industrial Biotech 
This company started just over 10years ago in china and had a huge commercial scale 
production of long chain dicarboxylic acids. It currently produces dibasic acids from C11-
C16 fatty acids.Cathay Industrial Biotech, China.2013. 
Sebacic India Limited 
This was a huge plant and first Company in India to produce Sebacic Acid which worth 
Rs.93 Crores with 10000 Metric Ton Per Annum of Sebacic acid. This company also 
produces Mixed Fatty Acid, Glycerin, 2-Octanol and Sodium Sulphate. Sebacic India 
Limited, India.2013. 
Verdezyne-Green chemistry 
This company produce the intermediates of plastics and nylon by using yeast fermentation 
technology. They have set up a platform where yeast can utilize a variety of plant-based 
oils and by-products of them. Dodecanedioic acid (C12) mainly used for lubricant and 
adhesives were traditionally produced from butadiene by chemical process but by using 
Yeast technology cost effective Dodecanedioic acid is produced. Total capacity of this 
plant is Adipic acid-6.3$ billion per annum, Sebacic acid- 600$ million per annum and 
Dodecanedioic acid- 250$ million per annum was produced.Verdezyne, USA.2013.  
Zibo Guangtong Chemical Co., Ltd 
A sub company from Zibo named Diacid plant had been started recently 1997 by Chinese 
Academy of Science. This plant produces long chain dicarboxylic acids by using biologic 
zymolysis methods. It produces C12, C13, C14, C15 diacids, dinitrile and diamine. This 
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company has ISO9001 certification and got many awards globally. Zibo Guangtong 
Chemical Co., Limited, China.2013. 
 
Other Companies involved in diacids production 
 BioAmber, USA.2013. 
 Itaconix, USA.2013. 
 Myriant, USA.2013. 
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3. AIM 
1) To construct plasmid vectors containing codon-optimised Cre-recombinase and marker 
genes with organism- specific promoters and terminators for Yarrowia lipolytica and 
Pichia guilliermondii 
 
2.) To test the constructed Cre-recombinase vectors by removing the antibiotic marker 
from strains where a gene encoding enzymes of β-oxidation (MFE2) had been deleted. 
 
3.) To overexpress the first enzymes of ω-oxidation (P450 hydroxylase and reductase) in 
the strains were β-oxidation is blocked. 
 
4.) To test the dicarboxylic acid production of the constructed strains. 
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4. MATERIALS AND METHODS 
4.1 Yeast and bacterial strains 
Two different yeast strains had been used in this work: The first strain is Yarrowia lipo-
lyticaC-00365 and the second yeast strain is Pichia guilliermondiiC-72064 from VTT 
culture collection.According to VTT studies both of them were capable toalkane utiliza-
tion. 
 
Bacterial transformations had been carried with E. coli electrocompetent TOP10 
(Invitrogen, USA) and DH5α (F-, endA1, recA1, hsdR17, gyrA96, relA1, 
φ80dΔlacZM15) strains. 
4.2 Media and growth conditions 
4.2.1 Culture medium 
The standard YPD medium has 2 % Bactopeptone (BD, USA), 1% Bacto-yeast extract 
(BD, USA) and 2 % of Glucose (Sigma-Aldrich, Germany). 
 
Bacterial cultivations had been carried out in LB medium containing 1 % Bacto-
tryptone (BD, USA), 0.5 % Bacto-yeast extract (BD, USA) and 1% NaCl.The plasmid 
selection was carried by adding 100 µg/mlAmpicillin.LB agar plates were prepared by 
adding 1.5 % Bacto-agar (BD, USA). 
4.2.2 TE buffer 
TE buffer contains 10 mM Tris-HCl and 1 mM EDTA at pH 8.0. 
4.2.3 STET buffer 
Stet buffer contains  8% sucrose,  50mM Tris-HCL, pH 8.0, 50mM EDTA, 5% Triton X-
100. 
4.3 Genomic DNA isolation 
C-00365 andC-72064, which were grown on 10 ml of YPD overnight at +30°C in 250 
rpm,werecentrifuged for 5 minutes with 3000 rpm. Supernatant had been decanted and 
the pellet had been resuspended with 1 ml of sterile double distilled water and transfered 
into a new 1.5 ml tube. After 30seconds centrifugation, supernatantwas removed and pel-
let had been resuspended in residual liquid (10 µl). 0.2 ml of plasmid release solution (2% 
Triton X-100, 1 % SDS,100 mM NaCL, 10 mM Tris-HCL(pH 8),1 mM Na2 EDTA) and 
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0.1 ml of phenol,0.1 ml of chloroform:isoamyl alcohol (24:1) were added. After 0.3 grams 
of acid-washed glass beads was added, tubes were vortexes for 4minutes.0.2 ml of TE 
(pH 8) had been added and samples were centrifuged for 5 minutes at 13500 rpm. The 
upper (water) phase was transfered into a new tube. The phenol: chloroform: isoamyl 
alcohol step were repeated twice to increase the concentration of DNA.Upper phase was 
transfered into a new tube and 1 ml of cold 94% EtOH were added and tube was mixed 
by inverting, centrifuged for 20 minutes at 13500 rpm at +4° C, and the supernatant was 
removed. The pellet had been resuspended to 0.4 ml of TE (pH 8) and 1.5 µl of 20 mg/ml 
RNase was added and sample were incubated for 5minutes at +37° C and 1 ml of cold 
94% EtOH and 4 µl of 10 M ammonium acetate were added. After mixing sample was 
centrifuged for 20 minutes at 13500 rpm at +4° C and the supernatant was decanted. Pellet 
been washed with 0.3 ml of 70% EtOH, dried at room temperature, and resuspended in 
50 µl of TE (pH 8).DNA had been stored at +4° C. 
4.4 Plasmids and deletion/expression cassettes for Yar-
rowia lipolytica 
All PCR reactions were carried out with DyNAzyme II (Finnzymes,Finland),PhusionTM 
(Finnzymes,Finland) and DyNAzyme Ext (Finnzymes,Finland). All polymerases were 
used according to manufacturer’s protocol.Primers (Sigma-Aldrich, Germany) used in 
PCR reactions were listed in Table 1. All the restriction enzymes 
(KpnI,ApaI,EcoRI,EcoRV,HindIII,SacI,PvuI,PmeI,XhoI,XmnI) (New England Bi-
oLabs,USA) and Fast Digest Enzymes (Fermentas life Sciences, Finland), the T4 DNA 
ligase (New England BioLabs,USA) and Calf Intestinal Alkaline Phosphatase 
(Finnzymes,Finland) had been used and all protocols were followed by manufacures’s. 
Bacterial plasmid purifications were carried out by using QIAprep Spin Miniprep Kit(Qi-
agen GmbH,Germany). The DNA fragments separation had been carried out by using 1% 
agarose gels (SeaKem LE agarose BMA, USA). For the extraction of DNA fragments 
QIAquick Gel Extraction Kit (Qiagen GmH, Germany) was used. Same kitwas also used 
to purify PCR reactions. Gene Ruler TM 1kb Plus (Fermentas, USA) DNA ladder had been 
used as a standard marker. 
4.4.1 ARS plasmids for Yarrowia lipolytica 
ARS18 sequence was amplified from Yarrowia lipolytica C-00365 genomic DNA with 
BC1 and BC2 oligo pairs. These oligos were forward and reverse primers with KpnIre-
striction sites.These primers were designed according to available ARS consensus se-
quences.The amplified sequence had been cloned into pBluescript (B-786) by using KpnI 
restriction enzyme. 
 
Touch down PCR program been used to amplify ARS product: Initialization start 
of 98°C for 2minutes, denaturation step at 98C for 15sec, anealing step at 65 C for 30 sec 
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and extension step at 72°C for 1minute repeated for 13cycles followed by initialization 
start of 98° C for 15 sec, annealing step at 55°C for 30sec and extension step at 72°C for 
1minute repeated for 23cycles. 
 
Digestion reaction contains 10µl of 100 ng of insert (PCR product), 1 µl of KpnΙ 
enzyme, 2 µl of 10 X Fast enzyme buffer, 7µl of DDIW.The vector digestion has same 
reagents but insert is replaced by 2 µl of 400 ng of pBluescript (SK-). Restriction mixture 
were incubated at 37°C for 1hour. 
 
Reaction was loaded to 1% agarose gel and run at 150 V for 1 hour.  UV spectro-
photometer was used to visualize the bands and right size insert (1300 bp) and pBluescript 
vector (2900 bp) wereisolated. Bands been transfered into a new 1.5 ml micro centrifuge 
tube separately and products were extracted by using Gel extraction kit (QIAGEN). 
 
Vector was dephosphorylated byKpnI digestion:1 µg of vector, 2 µl of 10 X Fast 
Digest Buffer, 1 µl of KpnI enzyme, 1 µl of FastAP Thermo sensitive Alkaline Phospha-
tase, 14 µl of DDIW and incubated at 37° C for 10 minutes. Reaction were arrested by 
heating at 65° C for 15 minutes and samples been run on agarose gel at 150 V.FastAP 
Thermo sensitive Alkaline Phosphatase were used to dephosphorylate the vector. 
 
Three different ligation mixtures were prepared with and without insert and vec-
tor. Ligation mixture contained1 µl of vector,3 µl of insert,1 µl of T4 DNA ligase buffer,1 
µl of T4 DNA ligase and 4µl of DDIW. Vector and insert control was same but they were 
replaced by DDIW. The ligation mixture wasincubated at room temperature for 1 hour. 5 
µl of ligation mixture had been transfered to 40 µl of chemical competent E. colicells with 
chemically competent method and plated on ampicillin marker plates. Plasmid pBC7 was 
constructed. 
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4.4.2 CRE cassettes 
Promoter:    TEF1 (elongation factor 1-alpha) 
Terminator: Tdh3 (Triose phosphate dehydrogenase) 
Cre Recombinase 
 
 
 
Figure: 7. CRE cassettes 
 
The pBC1 were obtained from Gene Art with Cre recombinase cassette. Cre cassette con-
tainsin addition to codon optimised recombinase gene, elongation factor 1-alpha(TEF1) 
promoter and Triose phosphate dehydrogenase (Tdh3)terminator.This cassette were re-
stricted by usingEcoRΙ, SacΙ, PvuΙ.PvuI were used to cut pMA plasmid to avoid back-
ground.Crecassette been ligated to B786-pBluescript EcoRI and SacI sites. These liga-
tions and digestions were performed according tomanufacturer’s protocol. 
 
Plasmids containing Cre cassettes had been digested with EcoRΙ, SacΙ, PvuΙ : 1 
µl-EcoRΙ, 1 µl-SacΙ, 1 µl-PvuΙ,2 µl of 10 X Fast enzyme buffer,5 µl of 250 ng of insert 
and 10 µl of DDIW.The vector digestion contains same reagentsexcept PvuΙ were not 
added. Insert and vector samples used run on gel at 150 V for 45 minutes. Insert (2356 
bp) and vector (2950 bp) were isolated and extracted withGel extraction kit. 
 
Three ligation reactions had been performed with and without insert andvector: 2 
µl-linear vector DNA, 3 µl insert DNA, 1 µl of 10 X T4 ligation buffer,1 µl of T4DNA 
ligase and 3 µl of DDW were added.Controls were prepared similarly than above except 
insert and vector had replaced by DDIW. Ligation mixture were incubated at room tem-
perature for 2 hours. Electroporation had been performed with2 µl of ligation mixture 
which was transfered to 40 µl of electro competent cells. Electroporation were carried out 
with Bio-Radelectroporator as describe below. After electroporation 100µl of mixtures 
were transformed to LB+ ampicillin plates. pBC5 (pBluescript + Cre) plasmid was con-
structed. 
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4.4.3 HPH cassettes 
Promoter:     Eno2 (Enolase 2) with LoxP site 
Terminator:  Pgk1 (phosphoglycerate kinase) with LoxP site 
Hph marker 
 
 
Figure: 8.HPH cassettes 
 
The pBC4 had been obtained from Gene Art.Hph cassette contains in addition to Hph 
marker gene two LoxP sites at the corners of Enolase 2 (ENO2) promoter and phospho-
glycerate kinase (PGK) terminator. This fragment had restricted by using XhoΙ, PmeI, 
XmnI were used to cut pMA plasmid to avoid background.Hph markercassette had ligated 
to pBC5 (Cre) by using XhoI and EcoRV sites.These had been performed by manufac-
turer’s protocol and transformed into E.coli cells. 
 
Hph cassette was cloned into pBluescript + CRE(pBC5). Plasmid containing Hph 
cassettes had been digested with XhoΙ, PmeI, XmnI: 1 µl-XhoΙ, 1 µl-PmeΙ, 1 µl-XmnI. 2 
µl of 10 X Fast enzyme buffer,5.2 µl of 230 ng of insert and 10 µl of DDIW.The pBC5 
vector had digested with 1 µl- XhoΙ, 1 µl of EcoRV and it contains same reagents.Re-
striction digestion mixtures were incubated for 1hour at 37°C.  Insert and pBC5 vector 
samples were run on gel seperately at 135 volts for 60 minutes. Insert (2450 bp) and pBC5 
vector (5314 bp) was cut and extracted from Gel extraction kit. 
 
Three ligation reactions had been performed with and without insert and vector: 
2 µl-linear pBC5 vector DNA, 3 µl insert DNA(Hph), 1 µl of 10 X T4 ligation buffer,1 
µl of T4 DNA ligase and 3 µl of DDW was added. Controls were prepared similarly than 
above except insert and vector had replaced by DDIW. Ligation mixture was incubated 
at room temperature for 2 hours. Electroporation were performed with 2 µl of ligation 
mixture which was transfered to 40 µl of electro competent cells. Electroporation had 
been carried out with Bio-Rad electroporator as describe below. After electroporation 
100µl of mixture was transformed to LB+ ampicillin plates. pBC20 (pBluescript + Cre + 
Hph) plasmid had been constructed. 
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4.4.4 CRE + Hph + ARS 
ARS(pBC7) were cloned into pBluescript+CRE + Hph (pBC20). Plasmid containing 
pBlusecript+Hph cassettes+Cre cassettes and ARS (pBC7) were digested with 1 µl-
Kpn1,2 µl of 10 X Fast enzyme buffer,3 µl of 150 ng of insert and 14 µl of DDIW.The 
pBC20 vector had digested with 1 µl- KpnΙ and it contains same reagents. Restriction 
digestion mixtures had been incubated for 1 hour at 37°C.  Insert(pBC7) and pBC20 vec-
tor samples were been run on gel seperately at 135 volts for 90 minutes. Insert (1300 bp) 
and pBC20 vector (7571 bp) had cut and extracted from Gel extraction kit. 
 
Three ligation reactions were been performed with and without insert and vector: 
2 µl-linear pBC20vector DNA, 3 µl insert DNA (pBC7), 1 µl of 10 X T4 ligation buffer,1 
µl of T4 DNA ligase and 3 µl of DDW were added. Controls were been prepared similarly 
than above except insert and vector were replaced by DDIW. Ligation mixture were in-
cubated at room temperature for 1.5 hours. Electroporation had been performed with 2 µl 
of ligation mixture which was transfered to 40 µl of electro competent cells. Electro-
poration was carried out with Bio-Rad electroporator as describe below. After electro-
poration 100µl of mixtures were transformed to LB+ ampicillin plates. pBC27 
(pBluescript + Cre + Hph + ARS) plasmid had been constructed. 
 
4.5 Nicotiana Tabacum P-450 hydroxylase and Arabidop-
sis thaliana P450reductase 
 
Figure:9. Cloning of overexpression cassette with Nat resistance to Yarrowia lipolytica. 
Genes to overexpress 
Nicotiana tabacum cytochrome P450-dependent fatty acid hydroxylase (CYP94A5) was 
1536bps long and it’s accession number is AF092916.  
 
Arabidopsis thaliana NADPH-cytochrome P450 reductase was 2079bp long and 
it had been expressed previously by Tijet et.al, 1998 and Urban et.al, 1997. NCBI Acces-
sion number is X66016The existing over expression cassette were constructed by Jessica 
Marcon in VTT 2011 
Table 1.Primers (Sigma-Aldrich, Germany) used in Yarrowia lipolytica. 
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Name Sequence Use 
ARS_KpnI_frw 
 
ACTGGGTACCGGATC
CCAATATTACACC 
amplification of Y.lipolytica ARS with 
KpnI sites 
ARS_KpnI_rev 
ACTGGGTACCGATCC
AGTCTACACTGAT 
amplification of Y.lipolytica ARS with 
KpnI sites 
Tef1_promoter_frw1 AGCCAGACCGATAGC 
Colony PCR and for sequencing in order to 
confirm Cre cassettes 
Tef1_promoter_frw2 
ATCCGGGTAACCCAT
GC 
Colony PCR and for sequencing in order to 
confirm Cre cassettes 
Tef1_promoter_rev1 TCGCTCCACTCTACG 
Colony PCR and for sequencing in order to 
confirm Cre cassettes 
Cre_frw1 
AGGACGTGCGAGACT
AC 
Colony PCR and for sequencing in order to 
confirm Cre cassettes 
Cre_frw2 
GGCCGAACTAAGACC
CTTGTG 
Colony PCR and for sequencing in order to 
confirm Cre cassettes 
Cre_frw3 
TCTGAGACTGGCGCT
ATGGTG 
Colony PCR and for sequencing in order to 
confirm Cre cassettes 
Eno2_promoter_frw1 
GCGGTCATATCACGCT
ACAC 
Colony PCR and for sequencing in order to 
confirm Hph cassettes. 
Eno2_promoter_frw2 
GGCCATGCAGTCGGA
TTTG 
Colony PCR and for sequencing in order to 
confirm Hph cassettes. 
Eno2_promoter_rev1 
ACTGCCTACACGTTAC
C 
Colony PCR and for sequencing in order to 
confirm Hph cassettes. 
Hph_frw1 
CGTGCTCCGAGTGAA
CTCTTG 
Colony PCR and for sequencing in order to 
confirm Hph cassettes. 
Hph_frw2 CTCGACGAGCTTATGC 
Colony PCR and for sequencing in order to 
confirm Hph cassettes. 
Hph_frw3 GCAACTTCGACGACG 
Colony PCR and for sequencing in order to 
confirm Hph cassettes. 
MFE2 3’ 
TCGTAGGTCATGCCGT
TTCCC 
Colony PCR and to confirm the deletion of 
Nat marker. 
MFE2 5’ 
GACCCTCTACTGATCT
CACACTTCC 
Colony PCR and to confirm the deletion of 
Nat marker. 
Reductase A.T. 5' AAGCCCTCAGCGGTT 
Colony PCR and to confirmNicotiana tab-
acum reductase gene sequence. 
Reductase A.T. 3' GTGGACCAGGGCGT 
Colony PCR and to confirm Nicotiana tab-
acum reductase gene sequence. 
TPI term 3' 
CAACCGTAGAGGTCC
ATGT 
Colony PCR and to confirm Nicotiana tab-
acum reductase gene sequence. 
TPI term 5' 
TTGGATTAGATGTAC-
CGGC 
Colony PCR and to confirm Nicotiana tab-
acum reductase gene sequence. 
NTgene5 
GAAGATGCCGTTAGA-
GAGG 
Colony PCR and to confirmNicotiana tab-
acum reductase gene sequence. 
TDH promo 
AAACGCTGCTG-
GAGCT 
Colony PCR and to confirmNicotiana tab-
acum reductase gene sequence. 
pTPI 3' 
GGGTGGGGTTA-
GAAATACAGT 
Colony PCR and to confirmNicotiana tab-
acum reductase gene sequence. 
tPGK 5' 
GGATGTGCAGA-
TACTTGTACC 
Colony PCR and to confirmNicotiana tab-
acum reductase gene sequence. 
TDH promo 
TCGTAGGTCATGCCGT
TTCCC 
Colony PCR and in order to confirm the 
deletion of Nat marker. 
 
Jessica Marcon constructed the overexpression cassette and the cassette contains 
Nicotiana tabacum P-450 + Arabidopsis thaliana reductase. The cassette was isolated 
with Plasmid isolation kit were digested with 1 µl Asc1, 1 µl : Not1, 2 µl of 10 X Fast 
enzyme buffer,5 µl of 100 ng of insert and 11 µl of DDIW. Restriction digestion mixtures 
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were incubated for 1.5 hour at 37°C.  Incubated samples had been run on gel at 150 volts 
for 35 minutes. Over expression cassette was cut and extracted from Gel extraction kit. 
 
PLASMID CONSTRUCTION 
 
 
Figure: 10.Plasmid pBC5 (pBluescript+CRE)  Figure: 11. Plasmid pBC4 (pMA+Hph) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure:12. Plasmid pBC20 (pBluscript+Cre+Hph) 
 
The above figure explains the construction of expression plasmid.pBC4 had been re-
stricted with EcoRV/XhoΙ/ (XmnI to cut pMA plasmid) and ligated to pBC5 (Asdescribed 
above). pBluescript with Cre recombinase and Hph marker had been obtained. 
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Figure:13. Plasmid pBC20                                       Figure:14. Plasmid pBC7        
(pBluecript+Cre+Hph)      (pBluscript+ARS)                                                    
     
 
 
Figure 15. Plasmid pBC27 (pBluescript+Cre+Hph+ARS) 
 
The expression plasmids pBC7 was restricted with KpnI and cloned to pBC20 (pBlue-
cript+Cre+Hph) as explained above. Final construct (pBluescript+Cre+Hph+ARS) had 
been obtained. 
4.6 Transformations 
4.6.1 E. Coli transformation 
Both chemically competent cells and electro competent cells had been usedwith bacterial 
transformations. Chemically competent cells were thawn on ice for 20 minutes and 10 µl 
of ligation mixtures were added, chilled on ice for 30 minutes and heat shock was given 
at +42°C for 30 seconds. 100 µl of mixtures were plated on LB+ ampicillin resistance 
plates. 
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GenePulser apparatus (Bio-Rad, USA) performed bacterial transformations by 
electrophoresis. 40 µl of electro competent cells had been used in each transformation. 2 
µl of plasmid DNA was added to electro competent cells. Electroporation were performed 
by following settings: 25 µF, 200 Ω and 2.5 kV. After the electroporation, in 0.2 mm 
electroporation cuvette (BioRad,USA),1 ml of SOC medium was been added and cells 
were incubated for one hour in +37° C and shaken it by 250 rpm.LB+ ampicillin plates 
had been used for plasmid selection. 
4.7 STET 
Bacterial cell mass were suspended in 50 µl of cold STET buffer and after 15 minutes 
vortex, 4 µl (10 mg/ml) of lysozyme solution had been added. Tubes were incubated for 
1 minute at 95 °C heat block and after 10minutes at 13500rpm centrifugation, pellet been 
removed by sterilized toothpick and 40 µl of isopropanol was added to the supernatant, 
centrifuged for 15 minutes at 13500 rpm. Supernatant had been discarded and pellet has 
been washed with 200 µl of 70% ethanol.  After centrifugation for 30seconds at 13500 
rpm supernatant were discarded. Pellet were dried completely at room temperature and 
resuspended in 15 µl of pH 7.5 of TE buffer.   
4.8 Yarrowia lipolytica transformation 
MFE2 deleted strain 05 were inoculated in 5ml of liquid YPD medium at pH 4in 100 ml 
flask. Cells had been grown for 7 hours at +28 °C. After 7 hours cells were been diluted 
into three different dilutions: 0.1,1 and 5 µl in 15 ml of fresh YPD medium at pH 4 in 250 
ml flask.These three dilutions were grown overnight at +28 °C. 9*107  cells from the cul-
ture having OD600 = 1- 2 were harvested. After 4minutes centrifugation at 4000 rpm, cells 
were washed with 15 ml of sterile water. Supernatant had been discarded and the pellet 
was resuspended in 0.1 M LiAc at pH 6.0 to cell concentration of 5*107 cells/ml. Cells 
been incubated at 1 hour in gentle shaking at +28°C.Herring sperm were used as a carrier 
DNA and carrier DNA had been incubated at +100°C for 15 minutes and placed on ice 
immediately. 100µl of cells had been transformed into 1.5 ml eppendorf and after 30sec-
ondscentrifugation, supernatant had discarded. To harvested cells, a mixture of 240 µl 
50% PEG 4000, 36 µl of 1M lithium acetate at pH 6.0, 5µl of 50µg of herring sperm 
DNA,79µl of sterile water and 2µg of  Cre plasmid DNA(pBC27) i.e., (p Bluescript + 
Cre + Hph+ ARS) were added. The mixtures were incubated in agitation for 30 minutes 
at +28°C at 250rpm and heat shock was given at 39°C for 5minutes. After 60 seconds 
centrifugation the cells been resuspended in 1 ml of YPD medium and incubated for 3 
hours at +28°C. Cells been plated on YPD+Hygromycin (400 µg/ml) plates.   
 
The overexpreesion cassette wastransformed into Yarrowia lipolytica Cre plasmid 
looped out strain- 1(ΔMFE clone 1). It had been transformed with the same method as 
above mentioned but the plasmid DNA had replaced by 2 µg of Over expression cassette 
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(Nt P450+At Reductase) and cells were plated on YPD + Nourseothricin (400 µg/ml) 
plates.  
4.9 Yeast colony PCR 
Yeast colony PCR been carried out with BC88 and BC90 oligo pair. This oligo pair is 
from 5’ and 3’ non coding regions of MFE2 gene. PCR reaction mix contained2 µl of 2 
mM dNTP–mix,2 µl of 10 x Dynazyme Buffer, 13.5 µl of DDW, 2 µl of both 20pmol/ µl 
concentration of primers and0.5 µl of Dynazyme ΙΙ enzyme.Small amount of yeast colony 
been added in 50 µl of 1 mg ml-1 Zymolase solution and incubated for 10 minutes at 
37°C.2.5 µl of PCR mixture was added to Zymolase treated cells and  PCR with 94°C 7 
minutes hot start, denaturation 94°C 45 sec, annealing 59°C 30 sec, elongation 72°C 1 
minute and repeated for the 34 cycles, final elongation at 72°C 10 minutes were carried 
out. 
 
To confirm the over expression cassette (Nt P450+At Reductase)yeast colony 
PCR was performed with different pairs of oligos same as above (oligos mentioned in 
Materials and Methods in Table 3). Reductase 5’ and Reductase 3’ oligo pair from Ara-
bidopsis thaliana P450 reductase. T PGK5’ and p TDH 3’ oligo pair where TPGK 5’ 
oligo was from terminator of Nicotiana tabacumand TDH 3’ was from promoter of Ara-
bidopsis thaliana P450 reductase. TDH5’ and TPI3’ oligo pair was from promoter and 
terminator of Arabidopsis thaliana reductase.  
4.10 Glycerol stock 
Selected yeasts strains were streaked on selective plates and were grown for 3days at 
+30°C.A mix of 1 ml of 15% glycerol and 0.9% NaCl solution were taken in Cryo tube 
and half of yeast growth had been looped and suspended in above buffer. Yeast strains 
were been stored at -80°C. 
 
Selected E. coli strains been grown in 2ml of LB-ampicillin medium at +37° C 250 
rpm. 500µl of fresh LB-ampicillin medium had been added to preculture and incubated 
for 30 minutes at +37° C in 250 rpm.860 µl of 87 % glycerol, 47 µl of 5 M NaCl, 595 µl 
of bacterial culture had mixed and incubated at room temperature for 2 hours. Cells were 
been stored at -80°C. 
4.11 Sequencing 
DNA sequencing reactions were performed by using Big DyeR sequencing kit(Applied-
Biosystems,USA) as described by Platt et al. (Platt et al., 2007). These reactions were 
analysed with ABI PrismR 3100 Genetic analyser (PE/Applied Biosystems,Perkin 
Elmer,USA). 
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4.12 Cultivations 
The complex SMIT YPD medium used in Yarrowia lipolytica cultivation had 1 % Bac-
topeptone (BD, USA), 1% Bacto-yeast extract (BD, USA) and 2 % of Glucose (Sigma-
Aldrich, Germany) at pH 5.5. 
 
Cultivations for diacid productions had been carried out as follows: 
Preculture-1 were prepared by adding yeast colony to 4ml of Smit-YPD medium in 15 ml 
tubes and grown at 250rpm overnight at +28°C or +30°C. Next day 100µl of preculture-
1 were added into 10ml of fresh Smit-YPD mediumand grown overnight at 250rpm. Fol-
lowing dayGrowth phase were started by adding 2ml of preculture 2 in 100ml of Smit 
YPD mediumin 500 ml flasks and grown overnight at 250rpm.Following day (Production 
phase):10 ml of 30 g/l nonanoate(pelargonic acid)or 1ml of oleicacid was added. 500µl 
of sample was collected every day from each cultivation and centrifuged at 6000 rpm for 
1 minute and supernatant had been collected. Residual glucose amount been checked with 
Glucose sticks and if glucose were utilized then 0,88g glucose per 1g biomass was been 
added.In addition, pH was been checked every day and adjusted to pH 8.0 with 4N 
NaOH.These cultivation steps were followed for 14days. 
Biomass had been calculated by formula [biomass g= 0, 1* 0, 7435 * OD.Volume of 40% 
glucose to be added = biomass*0, 88/0.4] 
4.13 High-performance liquid chromatography (HPLC) 
High performance liquid chromatography (HPLC) were used to analyse the residual glu-
cose amounts. Supernatant samples collected from cultivations (100 µl) were been diluted 
in 900 µl (50 mM H2SO4). Anninex HPX-87 H organic acid column (300 mm*7.8 mm) 
and fast acid analysis column (100 mm*7.8 mm) had been used. Columns were main-
tained at +55°C and 5 mM H2SO4 (Merck KgaA,Germany)were used an eluent with flow 
rate of 0.5 ml min-1.The running time of each sample was 40 minutes. Waters 2695 system 
with Waters 3410 RI detector (Waters, USA) was used. 
4.14 Gas chromatography-Mass Spectrometry (GC-MS) 
Supernatant samples (100µl) had been taken into 2ml eppendorf tubes.50 µl of 1 M HCL 
was been added and mixed thoroughly. Then 500 µl of TBME and 25 µl of internal stand-
ard (TriHeptadecanoic acid (C17:0 about 1g/l)) had been added.After 10minutes vor-
texing, the samples were placed on ice for 15 minutes.After centrifugation at 13500 rpm 
for 5minutes,theupper phase was been transfered into new GC-MS glass tubes. TBME 
extraction step was repeated by addition of 500 µl of TBME.The upper phase were again 
collected. 
 
The samples were been trimethylsilylated with MSTFA (N-methyl-N-trimethylsi-
lyltrifluoroacetamide; Pierce Chemicals, Rockford, IL, USA) at 80 °C for 20 minutes. An 
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Agilent 7890A GC combined with a 5975C mass selective detector had equipped with an 
Rtx®-5MS silica capillary column (15m, 0.25 mm ID, 0.25 µm (Restek, Bellefonte, PA, 
USA) were used to analyses. The oven temperature was increased from 70°C for 1minat 
a rate of 10°C/min to 270°C for 4min. The split ratio was 20:1 and the samples were 
injected by a Gerstel Maestro MPS 2 sampling system (Gerstel GmbH&Co.KG, Müll-
heim an der Ruhr, Germany). The data was collected at a mass range of 40-600 amu. 
Identification of compounds were based on retention times and mass spectral library com-
parison (NIST ’08, Scientific Instrument Services, Inc., Ringoes, NJ, USA).  
4.15 Plasmids and deletion/expression cassettes for Pichia 
guilliermondii 
4.15.1 ARS plasmids for Pichia guilliermondii 
ARS sequence been amplified from Pichia guilliermondii C-72064 genomic DNA with 
BC3 and BC4 primers. These oligos were forward and reverse primers with Apa1 sites. 
The primers were been designed from available published ARS sequences. The amplified 
sequence were cloned into pBlue script (B-786) by using ApaI restriction enzyme. ARS 
was constructed by using same Touch down PCR program and same method for cloning 
as decribed below. The restriction digestion enzyme is replaced by ApaI. 
 
4.15.2 CRE cassettes for Pichia guilliermondii 
Promoter:    TEF1 (elongation factor 1-alpha) 
Terminator: Tdh3 (Triose phosphate dehydrogenase) 
Cre Recombinase 
 
 
 
Figure: 16. CRE CASSETTES 
 
The pBC2 was obtained from Gene Art with Cre recombinase cassette. Cre cassette con-
tains in addition to codon optimised recombinase gene, elongation factor 1-alpha (TEF1) 
promoter and Triose phosphate dehydrogenase (Tdh3) terminator. This cassette were re-
stricted by using EcoRΙ, SacΙ, PvuΙ.PvuI was used to cut pMA plasmid to avoid back-
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ground. Cre cassette were ligated to B786-pBluescript EcoRI and SacI sites. These liga-
tions and digestions were performed according to manufacturer’s protocol. Electro-
poration was been carried out with Bio-Rad electroporator as describe above. Plasmid 
pBC6 (pBluescript + Cre) was constructed. 
4.15.3 HPH cassettes for Pichia guilliermondii 
 Promoter:     Eno2 (Enolase 2) with LoxP site 
Terminator:  Pgk1 (phosphoglycerate kinase) with LoxP site 
Hph marker 
 
Figure: 17. HPH CASSETTES 
 
The pBC3 was obtained from Gene Art. Hph cassette contains in addition to Hph marker 
gene two LoxP sites at the corners of Enolase 2 (ENO2) promoter and phosphoglycerate 
kinase (PGK) terminator. This fragment were restricted by using XhoΙ, PmeI and XmnI.  
XmnI were been used to cut pMA plasmid to avoid background. Hph marker cassette had 
been ligated to pBC6 (Cre) by using XhoI and EcoRV sites. These were performed by 
manufacturer’s protocol and transformed into E.coli cells.Transformation into E. coli had 
been carried out similarly than in above. Plasmid pBC8 with ARS sequence and Cre cas-
sette were constructed (pBC50). 
 
All the methods like  PCR for ARS(3.4.1), Restriction digestion, Agarose Gel 
electrophoresis, Ligation,  Plasmid isolation, Colony PCR, Cre cassettes(3.4.2) were per-
formed same as Yarrowia lipoytica and in order to confirm the Pichia guilliermondii plas-
mids Table 3 oligo’s were used. 
4.16 Gibson assembly 
This method had developed by Dr.Daniel Gibson at J.Craig Venter Institute and this 
method was licensed to New England’s BioLabs Inc., NEBuilder (http://neb-
uilder.neb.com/) were used to design primers for assembling DNA fragments. The pri-
mers with overlapping (15-25) nucleotide sequences between two adjacent DNA frag-
ments were designed.  
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Forward and reverse primers mentioned in Table 2. (primers with overlap for each 
adjacent DNA fragments) were placed in PCR reaction and PCR product had been am-
plified by Gibson assembly PCR primers. The 4 DNA fragments (pBluescript, ARS se-
quence, Cre cassette, Hph cassette) were been prepared for assembly and approximately 
total 1pmols concentrations were taken according to protocol. This Assembly reaction 
had been incubated in thermo cycler at 50 °C for 60 minutes. The reaction were transfered 
into Electro competent cells of DH5 alpha and Top10 by using GenPulser as described 
above. 
 
 
 
 
Figure 18 (a)    Figure 18 (b) 
Figure18. a.) Explains NEB fragments arrangement for Pichia guilliermondii construct 
and b.)Gibson assembly picture construct for Pichia guilliermondii. 
 
 
 
Figure:19. Plasmid pBC50 (pBluescript+ARS+Hph) 
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Table: 2. List of Primers used in Gibson assembly for Pichia guilliermondii constructs. 
S.No Use Amplify Region 
BC190 GGATTGTTGGTCAACGGGCTGCAGGAATTCGAT pBluescript  and Pg ARS 
flank  
BC191 CGACGGTATCGATAAGCTTGATATC 
GAATTCCTGCAGCCCGTTGACCAACAATCCCGA 
Pg ARS andpBluescript 
flank  
BC192 CGAAGTTATCCTGCAGGGCGGCCGC 
GTCGACACACATCACACG 
Pg ARS and Pg Hph flank  
BC193 GAGTCACAAGAGCGTGTGATGTGTGTCGAC 
GCGGCCGCCCTGCAGGAT 
Pg Hph and  Pg ARS flank  
BC194 AGTTTTGGTGAATTTTTCGGAATT 
CGCGGCCGCATCGATATAACTTCG 
Pg Hph andPg Cre flank  
BC195 CATTATACGAAGTTATATCGATG 
CGGCCGCGAATTCCGAAAAATTCACC 
Pg Cre and Pg Hph flank  
BC196 GCGGTGGCGGCCGCTCTAGA 
ACTAGTGGATCCCCCGAGCTCGCTGAATTTGTG 
Pg Cre andpBluescript 
flank  
BC197 TTCACAAATTCAGCGAGCTC  
GGGGGATCCACTAGTTCTAG 
pBluescript  and Pg Cre 
flank 
BC198 TATCGATAAGCTTGATATCGAATTCC 
TGCAGCCCGCGGCCGCCCTGCAGGAT 
PgHph, pBluescript and 
ARS flank  
BC199 TATACGAAGTTATCCTGCAGGGCGGCCGC 
GGGCTGCAGGAATTCGAT 
pBluescript andPg Hph 
flank  
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Table: 3. List of primers for constructing Pichia guilliermondiiplasmids 
 
Name Sequence Use 
Pg_ARS_ApaI_frw 
ACTGGGGCCCGTTGAC-
CAACAA 
TCCCGA 
amplifiyingP.guilliermondii 
ARS with ApaI sites 
Pg_ARS_ApaI_rev 
ACTGGGGCCCGTCGACACAC 
ATCACACG 
amplifyingP.guilliermondii 
ARS with ApaI sites 
Pg_Tef1_promoter_frw1 CGCGACGAACAAGATGATG Colony PCR and to confirm 
Cre cassettes 
Pg_Tef1_promoter_frw2 GAGAAGGAAGCCGCCGAATTG Colony PCR and to confirm 
Cre cassettes 
Pg_Tef1_promoter_rev1 CGAGGCGACGGGAACTTTATG Colony PCR and to confirm 
Cre cassettes 
Pg_Cre_frw1 CGAGCCAGAGGATGTGAGAG Colony PCR and to confirm 
Cre cassettes 
Pg_Cre_frw2 CATCGGAAGAACTAAGACC Colony PCR and to confirm 
Cre cassettes 
Pg_Cre_frw3 CATGGTGCGGTTGTTG Colony PCR and to confirm 
Cre cassettes 
Pg_Eno2_promoter_frw1 GAGTGGAGCGATTATGC Colony PCR and to confirm 
Hph cassettes 
Pg_Eno2_promoter_frw2 CAGAGCCATTGATTACATCG Colony PCR and to confirm 
Hph cassettes 
Pg_Eno2_promoter_rev1 GATTCGCAGCCATAGTATTG  Colony PCR and to confirm 
Hph cassettes 
Pg_Hph_frw1 TTAACTCCTGTGCTGACG Colony PCR and to confirm 
Hph cassettes 
Pg_Hph_frw2 GAATTGATGTTGTGGGCTG Colony PCR and to confirm 
Hph cassettes 
Pg_Hph_frw3 CCGCTGCTGTTTGGACTGAC Colony PCR and to confirm 
Hph cassettes 
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5. RESULTS 
5.1 Yarrowia lipolytica 
Table 4.The below table showsplasmids constructed in this work:  
Name Plasmid name Backbone Cloning sites selection strain 
pBC7 pBlue_Yl_ARS pBluescript  KpnI Ampicillin DH5
α 
pBC5 pBlue_Yl_Cre pBluescript  EcoRI/SacI Ampicillin DH5
α 
pBC20 pBlue_Yl_Cre_Hph pBluescript EcoRV,Pme1/Xho1 Ampicillin DH5
α 
pBC27 pBlue_Yl_Cre_Hph_ARS pBluescript Kpn1 Ampicillin DH5
α 
 
5.1.1 ARS-plasmid (pBC7) 
An ARS18 sequences were been amplified by using BC1 and BC2 oligo pair from Yar-
rowia lipolyticaC-00365 strain. These primers were designed  based on available pub-
lished sequence of ARS18.Clear amplified bands were been obtained when compared to 
negative control and the band size is 1300base pairs as expected. These were compared 
with 1kb Gene Ruler DNA ladder. Thus, the verified PCR products were been successful 
and confirmed by sequencing after cloned into pBluescript plasmid. 
 
 
 
 
 
 
 
Figure 20.The above gel picture explains the ARS18 sequence band and Ladder was on 
both the sides of a gel.Lane1-Lane9 contains amplified products of Yarrowia lipolytica 
and expected band is 1300bp. In the last row NC refers to negative control in PCR reac-
tion with water. 
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5.1.2 CRE-plasmid (pBC5) 
Synthetised CRE cassette had been cloned into pBluescript (SK-).The Colony PCR check 
were performed to the selected colonies with M13 forward andBC55 primers. M13 for-
ward primer is from pBluescript plasmid and BC55 is a reverse primer of Tef1 promoter 
from Cre cassette.Clear bands were obtained with 400bp as expectedwhen compared with 
1kb Gene Ruler.      
 
 
 
 
 
Figure 21. A colony PCR performed gel picture were seen and two kb-ladders were been 
placed on both the corners of the gel.Lane1-Lane24 has CRE colonies but Lane-15 had  
negative control. A clear band of 400bp was obtained. 
5.1.3 HPH + CRE - plasmid (pBC20) 
Synthetised Hph cassette were cloned into pBluescript+CRE plasmid(pBC5). Colonies 
were been verified by performing restriction digestion with EcoRI and XhoI.The expected 
band sizes were 5220bp and 2351 bp.  Lane 3, Lane 12 and Lane 24 have two bands with 
expected band sizes. The verification been successful and plasmids were confirmed by 
sequencing.  
 
Figure 22. The upper gel and lower gel kb- ladder on last rows of gel.Lane1-Lane28 were 
colonies (pBluescript+Cre+Hph) performed Restriction digestion. The expected bands 
were 5220bp and 2351bp 
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5.1.4 ARS+CRE+Hph -plasmid (pBC27) 
ARS18 cassettefrom pBC7 plasmid had been cloned into pBC20.Colonies were screened 
by performing restriction digestion with EcoRI and HindIII.A band size of 5800bp and 
3100bp were expected and they were seen in Lanes 4,6,9,12,24,25,26 and 28.The verifi-
cation was been successful and observed expected bands clearly. The constructed plas-
mids were been confirmed by sequencing. 
 
Figure 23. The gel had GeneRuler 1Kb kb-ladder at all the last rows of gel. Lanes1 –
Lanes30 were colonies (pBluescript ARS+CRE+Hph) performed Restriction Digestion 
and bands expected were 5800bp and 3100bp 
 
5.2 Nourceothricin marker and CRE plasmidloop Out 
Cre recombinaseconstructed plasmids (pBC27)   tested by transforming it to ΔMFE2 Yar-
rowia lipolytica strain. Colonies were been observed on YPD+Hygromycin (400µg/ml) 
plates.Selected transformants having pBC27 plasmid were cultured in 10ml YPD+Hy-
gromycin (400µg/ml) for three days. Fresh culture was prepared every dayfrom overnight 
culture. Serial dilutions with 0.9% NaCl had been plated on YPD+Triton- X plates. Col-
onies from YPD+Triton-X plates were been streaked on YPD, YPD+hygromycin 
(400µg/ml) and YPD+Nourceothricin (400µg/ml) plates. 
Totally 20 colonies been verified. All colonies were grown on YPD medium, but colonies 
1,6,12,13,18,19 did not grow on YPD+Hygromycin (400µg/ml) and no colonies had 
grown on YPD+Nourceothricin (400µg/ml) plates. This indicates there had been a suc-
cessful loop out of nourseothricin (400µg/ml) marker from genomic DNA and also Cre 
recombinase plasmid was been looped out from some of the MFE2 deleted Yar-
rowialipolytica transformants. 
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Figure 24 .  Left agar plate had YPD+Nourceothricin (400µg/ml) and right plate had 
YPD+Hygromycin (400µg/ml) and down plate contains only YPD mediu 
5.2.1 PCR confirmation of the Nat marker loop out transformant 
Yeast colony PCR were been performed with the selected loop out transformantswith 
BC88 andBC90 oligos.BC88 had a nucleotide sequence from MFE 5' flank forward and 
BC90 hasMFE 3' flank reverse. These oligo’s were from out side to MFE2 deletion cas-
sette in order to confirm whether nourseothricin marker had been looped out. . 
 
A 832bp fragment were expected and they had obtained in all colonies. But Lane 
1, Lane 4 and Lane5 had bright bands whereas Lane2, Lane 3 and Lane 6 had pale 
bands.Lane-7 is a negative control without any band. This indicates there was been a 
successful loop out of nourseothricin marker from the above selected colonies. 
 
 
 
 
Nourceothri-
cin 
(400µg/ml) 
YPD 
Hygromycin 
(400µg/ml) 
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Figure 25.The figure explains L-ladder on the both corner sides of the gel. Lanes 1-6 
shows clear bands of 832bp and Lane-7 had a NC-negative control. 
5.2.2 PCR confirmation of the Nicotiana Tabacum P-450 hydroxylase and 
Arabidopsis thaliana P450reductase 
To over express the cytochrome P450complex in MFE2 deleted strain, cassette containing 
Nicotiana tabacum P-450 hydroxylase and Arabidopsis thalianareductase were trans-
formed in Y. lipolytica. Primers NT gene 5’ and pTPI 3’ had been used to check colony 
PCR. NT gene 5’ oligo is from Nicotiana tabacum gene and pTPI 3’ reperesents promoter 
TPI of Nicotiana tabacum. This oligo pair is chosen from inside the cassette because it’s 
hard to find where the cassette was attached in the whole genome.There are other oligo 
pairs to check the complete cassette. 
 
 
 
Figure 26.  The very left and right corner L-indicates ladder.Lane1 to Lane 14 were dif-
ferent colonies.Lane-15 was been a positive control. When compared to Positive control 
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Lane-1 shows the equal base pairs. A clear band of 640base pairs was expected and 
seen. 
To reconfirm the above results yeast colony PCR were performed for three colonies with 
different oligo pairs (oligos mentioned in Materials and Methodsin Table3).All the oligo 
pairs showed the positive results. Reductase 5’ and Reductase 3’ oligo pair from Ara-
bidopsis thaliana P450 reductase. T PGK5’ and pTDH 3’ oligo pair where TPGK 5’ oligo 
was from terminator of Nicotiana tabacumand TDH 3’ was from promoter of  Arabidop-
sis thaliana P450 reductase. TDH5’ and TPI3’ oligo pair was from promoter and termi-
nator of Arabidopsis thaliana reductase .This indicates the presence ofNicotiana Taba-
cum P-450hydroxylase and Arabidopsis thalianareductase gene. 
 
 
Figure 27. In the above gel picture L-indicates Ladder and Lanes 1, 2, 3 all were positive 
with a clear band of 1500base pairs.A combination of Reductase5’ and Reductase3’ oli-
goproved the presence of the Reductase gene in MFE deleted loop out marker strains. 
This indicates the integration of  Cytochrome P450 complex cassette was been successful. 
5.2.3 Yarrowia lipolytica ARS 
The Yarrowia lipolytica sequences had been analysed by multiple sequence alignment. 
There were two published sequences available for Yarrowia lipolytica. Namely, ARS18 
and ARS68.A comparison were performed to both published sequences and with pBC7 
sequence from this work with Clustal W(Multiple sequence alignment).  
 
1-Yarrowia_70 -This represents pBC7 sequence from this work.     
2-Yarrowia_18ARS-This represents published sequence of ARS18 available from Pub-
Med.  
3-Yarrowia_68ARS-This represents ARS68 published sequence from PubMed.  
 
Pairwise alignment showed that ARS sequence in pBC7 to 18ARS was more homolo-
gywith a great score of 99.69.Whereas ARS sequence in pBC7 and Yarrowia_68ARS 
alignment score was 64.56.This indicates that ARS sequence of this work was more re-
lated to Yarrowia lipolytica ARS18 sequence.This shows pBC7 was almost equal to 
ARS18.     
 
 
 
 
Table 5.Scores Table of ARS Yarrowia lipolytica  
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1-Yarrowia_70>GGATCCCAATATT--ACACCCAA-------------------GTAGCATG   29 
2-Yarrowia_18ARS>GGATCCCAATATT--ACACCCAA-------------------GTAGCATG   29 
3-Yarrowia_68ARS>GGATCCGAATTTTCAGAACCTAATTTATCTGTTACCCGGCCTGTGGCTCG   50 
                  ****** *** **    *** **                   ** **  * 
 
1-Yarrowia_70>CATAAGCTAAAAGT-----AACTCGCAGCG-----------------CAC   57 
2-Yarrowia_18ARS>CATAAGCTAAAAGT-----AACTCGCAGCG-----------------CAC   57 
3-Yarrowia_68ARS>CACAGCTTAAAAATGGTCAAACTTTCCCCTTCTTGTCTTTTTTTCCTCAC  100 
                  ** *   ***** *     ****  *  *                  *** 
 
1-Yarrowia_70>ACCGTGCAGATTC-----------------ATAAGTCTATGATTA-----   85 
2-Yarrowia_18ARS>ACCGTGCAGATTC-----------------ATAAGTCTATGATTA-----   85 
3-Yarrowia_68ARS>ATTCATCAGGTTCTTGTCTTGATCTTTCAAGTGAGTAT-TAATTACCGAC  149 
                  *     *** ***                  * *** * * ****      
 
1-Yarrowia_70>----------------------ATTGAACGCC-------AATAACC----  102 
2-Yarrowia_18ARS>----------------------ATTGAACGCC-------AATAACC----  102 
3-Yarrowia_68ARS>CTTGGTTCTTCATTGGGAGAGCATTGGAAGCCGTGGTGCAGCAACCACAA  199 
    **** * ***       *  ****    
 
1-Yarrowia_70>--CGGCT-------TACTACA------------------AGTACAAGTAG  125 
2-Yarrowia_18ARS>--CGGCT-------TACTACA------------------AGTACAAGTAG  125 
3-Yarrowia_68ARS>AACGGTTCTTCCCCTTCGATACCTTCTTGCCTGCCTTTCAATACAAGTCG  249 
                    *** *       * * * *                  * ******* * 
 
1-Yarrowia_70>GTATACATAGCGGT------------------------------------  139 
2-Yarrowia_18ARS>GTATACATAGCGGT------------------------------------  139 
3-Yarrowia_68ARS>GCTCGATTAGCGGTGGTCGCCCCCGCCAGCGGAGAACATGGAACTAACCC  299 
                  *      *******                                     
 
1-Yarrowia_70>--AATGAA---TCATTAGAACAAAAAAAAAAACAAA-----------AAA  173 
2-Yarrowia_18ARS>--AATGAA---TCATTAGA--AAAAAAAAAAACAAA-----------AAA  171 
3-Yarrowia_68ARS>AGAATGAGAGCTAAGTGGAGAAAGAAGAGAGTCAGACGACTCAAGCGAAA  349 
                    *****    * * * **  ** ** * *  ** *           *** 
 
1-Yarrowia_70>-------------------------AAACAA---------AAC-------  182 
2-Yarrowia_18ARS>-------------------------AAACAA---------AAC-------  180 
3-Yarrowia_68ARS>GCGCCGCAAGGTCCGAGCTCGATCCAAATAAGCGGTTTTTAACGGAGATT  399 
                                           *** **         ***        
 
1-Yarrowia_70>-------AAACTG--------------------TTGTGGATG----CATC  201 
2-Yarrowia_18ARS>-------AAACTG--------------------TTGTGGATG----CATC  199 
3-Yarrowia_68ARS>TAACACTAAATCGAAGAACTTTTCCCGTTTCATTTGCGAATGAGCTCGTT  449 
                         ***  *                    *** * ***    * *  
 
1-Yarrowia_70>AACAG---------------------------------------TAGTAC  212 
2-Yarrowia_18ARS>AACAG---------------------------------------TAGT--  208 
3-Yarrowia_68ARS>AACAAAATCCCCCAGTTTTTTTATCCAGCTGTAAGGATTGACATTAGTAA  499 
                  ****                                        ****   
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1-Yarrowia_70>ATAGTTGTACAGTAGTACAT----------AGTT----------------  236 
2-Yarrowia_18ARS>----------------ACAT----------AGTT----------------  216 
3-Yarrowia_68ARS>TGAATTATTGTTTGGTATATTTAAATCTGTAGTTCCTTTCTGTCCGTGTC  549 
                                  * **          ****                 
 
1-Yarrowia_70>----------GTAC----GATGTACTTGTACTTGTAAA----------AG  262 
2-Yarrowia_18ARS>----------GTAC----GATGTACTTGTACTTGTAAA----------AG  242 
3-Yarrowia_68ARS>GGCAACTGTCGTACTCGTGATTTACTTGTATTGACGAATACTTACTGTAG  599 
                            ****    *** ******** *    **          ** 
 
1-Yarrowia_70>C----------------------AAAAATGTACAATATC-----------  279 
2-Yarrowia_18ARS>C----------------------AAAAATGTACAATATC-----------  259 
3-Yarrowia_68ARS>CGCACTCTGCTGCTACTGGTCGTAAGGATGTGCTATTTCGGTGTATGGTG  649 
                  *                      **  **** * ** **            
 
1-Yarrowia_70>------TCAGGGAGCGCAAC-------TTTTAC-----------------  299 
2-Yarrowia_18ARS>------TCAGGGAGCGCAAC-------TTTTAC-----------------  279 
3-Yarrowia_68ARS>GGTTTTTTGGGGGTCGGAACCGAAGACTGTTACACGGGCACGGCTCGTTG  699 
                        *  ***  ** ***       * ****                  
 
1-Yarrowia_70>--------------------------------------------------  299 
2-Yarrowia_18ARS>--------------------------------------------------  279 
3-Yarrowia_68ARS>TGTACACGCACAGAGCTCTTGCGAGTCATGTTGTAGCTAGCTCGTCGTGT  749 
 
 
1-Yarrowia_70>-----------------GTTCGAAGA------------ACAATGTACCGC  320 
2-Yarrowia_18ARS>-----------------GTTCGAAGA------------ACAATGTACCGC  300 
3-Yarrowia_68ARS>TCAGGAACTGTTCGATGGTTCGGAGAGAGTCGCCGCCCAGAACATAC-GC  798 
                               ***** ***            * **  *** ** 
 
1-Yarrowia_70>GTACCG----------------------------CATTCTGG-------A  335 
2-Yarrowia_18ARS>ATACCG----------------------------CATTCTAG-------A  315 
3-Yarrowia_68ARS>GCACCGATGTCAGCAGACAGCCTTATTACAAGTATATTCAAGCAAGTATA  848 
                   ****                             ****  *       * 
 
1-Yarrowia_70>TTC-TGCGGAACGTCTAACCTGGAAATACGATT-----------------  367 
2-Yarrowia_18ARS>TTC-TGCGGAACGTCTAACCTGGAAATACGATT-----------------  347 
3-Yarrowia_68ARS>TCCGTAGGGTGCGGGTGATTTGGATCTAAGGTTCGTACTCAACACTCACG  898 
                  * * *  **  **  * *  ****  ** * **                  
 
1-Yarrowia_70>------TTTTTTTTCTTTCATTTTTTT-----------------------  388 
2-Yarrowia_18ARS>------TTTTTTTTCTTTCATTTTTTT-----------------------  368 
3-Yarrowia_68ARS>AGCAGCTTGCCTATGTTACATCCTTTTATCAGACATAACATAATTGGAGT  948 
                        **   * * ** ***  ****                        
 
1-Yarrowia_70>-TGCTTCTTCAAAAG---------TATGGTAATTTCCTACCATTACAGT-  427 
2-Yarrowia_18ARS>-TGCTTCTTCAAAAG---------TATGGTAATTTCCTACCATTACAGT-  407 
3-Yarrowia_68ARS>TTACTTACACACGGGGTGTACCTGTATGAGCACCACCTACAATTGTAGCA  998 
                   * ***   **   *         ****   *   ***** ***  **   
 
1-Yarrowia_70>-TGACACT------------------GAACGA------GGGGGGATTGAA  452 
2-Yarrowia_18ARS>-TGACACT------------------GAACGA------GGGGGGATTGAA  432 
3-Yarrowia_68ARS>CTGGTACTTGTACAAAGAATTTATTCGTACGAATCACAGGGACGGCCGCC 1048 
                   **  ***                  * ****      ***  *   *   
 
1-Yarrowia_70>TTTA-------AGCAAAAA-----------------ATTAAATCAA----  474 
2-Yarrowia_18ARS>TTTA-------AGCAAAAA-----------------ATTAAATCAA----  454 
3-Yarrowia_68ARS>CTCACCGAACCAGCGAATACCTCAGCGGTCCCCTGCAGTGACTCAACAAA 1098 
                   * *       *** ** *                 * * * ****     
 
1-Yarrowia_70>--------AATACCTTT--ATG-TATCCAGCCCATG-----TA----ATA  504 
43 
 
2-Yarrowia_18ARS>--------AATACCTTT--ATG-TATCCAGCCCATG-----TA----ATA  484 
3-Yarrowia_68ARS>GCGATATGAACATCTTGCGATGGTATCCTGCTGATAGTTTTTACTGTACA 1148 
                          ** * ***   *** ***** **  **      **    * * 
 
1-Yarrowia_70>AACA------------------------------------------AAAG  512 
2-Yarrowia_18ARS>AACA------------------------------------------AAAG  492 
3-Yarrowia_68ARS>AACACCTGTGTAGCTCCTTCTAGCATTTTTAAGTTATTCACACCTCAAGG 1198 
****                                          ** * 
1-Yarrowia_70>G---------ATTATATAA-----------------CAAGAAA-TAAATA  535 
2-Yarrowia_18ARS>G---------ATTATATAA-----------------CAAGAAA-TAAATA  515 
3-Yarrowia_68ARS>GGAGGGATAAATTAAATAAATTCCAAAAGCGAAGATCGAGAAACTAAAT- 1247 
                  *         **** ****                 * ***** *****  
 
1-Yarrowia_70>TATACCTTTAA---------TGGATCATTA------GAATAAAAATAATA  570 
2-Yarrowia_18ARS>TATACCTTTAA---------TGGATCATTA------GAATAAAAATAA--  548 
3-Yarrowia_68ARS>TAAAATTCCAAAAACGAAGTTGGAACACAACCCCCCGAAAAAAAACAAC- 1296 
                  ** *  *  **         **** **  *      *** ***** **   
 
1-Yarrowia_70>AATACGAGAAGCACACCAGAG-AAGC--------------TTTTTGATTG  605 
2-Yarrowia_18ARS>-ATACGAGAAGCACACCAGAG-AAGC--------------TTTTTGATTG  582 
3-Yarrowia_68ARS>-AAACAAAAAACCCAACAAAATAAACAAAAACAAAATAAATATATAACTA 1345 
                   * ** * ** * ** ** *  ** *              * * * * *  
 
1-Yarrowia_70>CCACTATACCGCTA----CTTTGGTAT--ATTCTTATTATAATT------  643 
2-Yarrowia_18ARS>CCACTATACCGCTA----CTTTGGTAT--AT-CTTATTATAATT------  619 
3-Yarrowia_68ARS>CCAGTATCTGACTAAAAGTTCAAATACTCGTACTTACAACAAATAGAAAT 1395 
                  *** ***    ***     *    **    * ****  * ** *       
 
1-Yarrowia_70>------GTTGAA--TTTGCAAGATAGAATGTGC--CATTCATTGG---AG  680 
2-Yarrowia_18ARS>------GTTGAA--TTTGCAAGATAGAATGT----CATTCATTGG---AG  654 
3-Yarrowia_68ARS>GAGCCGGCCAAAATTCTGCAGAAAAAAATTTCAAACAAGTACTGGTATAA 1445 
                        *   **  * ****  * * *** *    **   * ***   *  
 
 
1-Yarrowia_70>AGAAATCGAAGGAATATGTGGGA-TGAAATGAC--TAGAAGT--------  719 
2-Yarrowia_18ARS>AGAAATCCAAGGAATATGTGGGA-TGAAATGAC--TAGAAGT--------  693 
3-Yarrowia_68ARS>TTAAATT-AAAAAACACATCAAAGTATCATAACGTTAGTTATTTTATTTT 1494 
                    ****  **  ** *  *   * *   ** **  ***   *         
 
1-Yarrowia_70>-----ATGAACAATGAGAATAGTACATACTTGTACCTGT--ATTTCTAGA  762 
2-Yarrowia_18ARS>-----ATGAACAATGAGAATAGTACATACTTGTACCTGT--ATTTCTAGA  736 
3-Yarrowia_68ARS>ATTTAATAAAAGAAAACAACAAGATGGGCTCAAAACTTTCAACTTATACG 1544 
                       ** **  *  * ** *  *    **   * ** *  * ** **   
 
1-Yarrowia_70>AGAGA----GAAAGACAGTTGAGTGT--------GTGATTCTCGTC--CA  798 
2-Yarrowia_18ARS>AGAGA----GAAAGACAGTTGAGTGT--------GTGATTCTCGTC--CA  772 
3-Yarrowia_68ARS>ATACATACCAAATAACAATTTAGTATTTATCTAAGTGCTTTTCGTAGATA 1594 
                  * * *     **  *** ** *** *        *** ** ****    * 
 
1-Yarrowia_70>AT--AATA-------ATCTCAATAGTA-ACGTGTGAATAGCTGTTCTTTG  838 
2-Yarrowia_18ARS>AT--AATA-------ATCTCAATAGTA-ACGTGTGAATAGCTGTTCTTTG  812 
3-Yarrowia_68ARS>ATGGAATACAAATGGATATCCAGAGTATACACATGGATAG-TATACACTG 1643 
                  **  ****       ** ** * **** **   ** **** * * *  ** 
 
1-Yarrowia_70>ATAGTTGATATTTCTCGATGACTATTTATGTTG-----TACAAGGGATT-  882 
2-Yarrowia_18ARS>ATAGTTGATATTTCTCGATGACTATTTATGTTG-----TACAAGGGATT-  856 
3-Yarrowia_68ARS>ACA--CGACAATTCTGTAT--CTCTTTATGTTAACTACTGTGAGGCATTA 1689 
                  * *   ** * ****  **  ** ********      *   *** ***  
 
1-Yarrowia_70>---------------------TTTTTCGTT--GCTGT-TGA----TTTCG  904 
2-Yarrowia_18ARS>---------------------TTTTTCGTT--GCTGT-TGA----TTTCG  878 
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3-Yarrowia_68ARS>AATAGAGCTTGATATATAAAATGTTACATTTCACAGTCTGAACTTTTGCA 1739 
                                       * ** * **   * ** ***    ** *  
 
1-Yarrowia_70>AATTAGGCAATGC----AGATATCATTTATG--CT-------------AT  935 
2-Yarrowia_18ARS>AATTAGGCAATGC----AGATATCATTTATG--CT-------------AT  909 
3-Yarrowia_68ARS>GATTACCTAATTTGGTAAGATATTAATTATGAACTGAAAGTTGATGGCAT 1789 
                   ****   ***      ****** * *****  **             ** 
 
1-Yarrowia_70>CCATA--TTT-----AAGAT----TTC--------------------CCA  954 
2-Yarrowia_18ARS>CCATA--TTT-----AAGAT----TTC--------------------CCA  928 
3-Yarrowia_68ARS>CCCTAAATTTGATGAAAGATGAAATTGTAAATGAGGTGGTAAAAGAGCTA 1839 
                  ** **  ***     *****    **                     * * 
 
1-Yarrowia_70>TACGCATTT---------ATAACATTTATTCTACATAAAT---TGTTAAA  992 
2-Yarrowia_18ARS>TACGCATTT---------ATAACATTTATTCTACATAAAT---TGTTAAA  966 
3-Yarrowia_68ARS>CAGTCGTTTTGTTTTGAGATACCATCATCTCTAACGAAATATCTATTAAA 1889 
                   *  * ***         *** ***    ****   ****   * ***** 
 
1-Yarrowia_70>TGAACGAACTGCCATTATAAATTGTTTCCTAAATAGGAAGTGTTTTTCAT 1042 
2-Yarrowia_18ARS>TGAACGAACTGCCATTATAAATTGTTTCCTAAATAGGAAGTGTTTTTCAT 1016 
3-Yarrowia_68ARS>-AATCTCAGTGTGATCATGAGTCATTGCCATCCTGGAAAATGTCAT-CAT 1937 
                    * *  * **  ** ** * *  ** **    * * ** ***  * *** 
 
1-Yarrowia_70>AAAGCAAGTA-----AGTTGTCTAATAATACTAAGTA-ATA--------- 1077 
2-Yarrowia_18ARS>AAAGCAAGTA-----AGTTGTCTAATAATACTAAGTA-ATA--------- 1051 
3-Yarrowia_68ARS>G--GCTGATATTTCTAACTGTTTACTTGAGATAAATATATATTTACAAGA 1985 
 
                 **   **     *  *** ** *     *** ** ***          
 
1-Yarrowia_70>---------AAAATAAGTTCA--TACAATATATTT-TGAGAACATCATTT 1115 
2-Yarrowia_18ARS>---------AAAATAAGTTCA--TACAATATATTT-TGAGAACATCATTT 1089 
3-Yarrowia_68ARS>ACTTCCCTTGAAATTAATTTAGATATAAAATGTTTGCGGGCAAGTTACTA 2035 
                            **** * ** *  ** ** ** ***  * * *  * * *  
 
1-Yarrowia_70>GGAGGCGGTAGATGGAGTCTGTTTATTA----TTA--AACA--------- 1150 
2-Yarrowia_18ARS>GGAGGCGGTAGATGGAGTCTGTTTATTA----TTA--AACA--------- 1124 
3-Yarrowia_68ARS>CGAGG-AATAAATTATATCTGTTGACTAGAAGTTATGAACATTCAGTATA 2084 
                   ****   ** **    ****** * **    ***  ****          
 
1-Yarrowia_70>-ATGCGAG----ATGACC--CCTTAAAT-------ATTGAGAACATCAGT 1186 
2-Yarrowia_18ARS>-ATGCGAG----ATGACC--CCTTAAAT-------ATTGAGAACATCAGT 1160 
3-Yarrowia_68ARS>TATGCACATATAATAACCAACTTCGAATTTTCCAAATTAGGAA-GTAAAT 2133 
                   ****       ** ***  * *  ***       ***  ***  * * * 
 
1-Yarrowia_70>TG--GAGGCGGCAGATGG-----AGTCTGTCTATTTAGCAATGGGACATG 1229 
2-Yarrowia_18ARS>TG--GAGGCGGCAGATGG-----AGTCTGTCTATTTAGCAATGGGACATG 1203 
3-Yarrowia_68ARS>TGTTATAATGAAACATAGTTTTAGGTTTTTATATATTATAATGGAATACG 2183 
                  **       *  * ** *      ** * * *** *   ***** * * * 
 
1-Yarrowia_70>ACTGTCACGTATCATCATGATGTA-TATATATAAT----------ACATA 1268 
2-Yarrowia_18ARS>ACTGTCA-GTATCATCATNATGTA-TATATATAAT----------ACATA 1241 
3-Yarrowia_68ARS>TCT-CCA-TTATTTTCGCCATCTAATTTATTTAATGAAAAAGTTTAGATA 2231 
                   **  **  ***  **   ** ** * *** ****          * *** 
 
1-Yarrowia_70>-------TAATATTATATAACACGATTTTTTT-------AAATTATTGGC 1304 
2-Yarrowia_18ARS>-------TAATATTATATAACACGATTTTTTT-------AAATTATTGGC 1277 
3-Yarrowia_68ARS>GATGATCTAATTTTATATATTAAAATAGATGGTGAGAGAAAAAAAATGGC 2281 
                         **** *******  *  **   *         ***  * **** 
 
1-Yarrowia_70>CCGAAAATTAATCAGTGTAGACTGGATC- 1332 
2-Yarrowia_18ARS>CCGAAAATTAATCAGTGTAGACTGGATC- 1305 
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3-Yarrowia_68ARS>TTGCATATATATATATATATAC-AGATCC 2309 
                    * * **  **   * ** **  ****     
5.3 Cultivations 
The strains used in cultivations were:Yarrowia lipolyticawild type C-00365, ΔMFE 1 and 
ΔMFE12, which were two different ΔMFE2strainsfromnourseothricin marker loop out 
experiment.ΔMFE+ Nt Rd+P450-16(1), ΔMFE+ Nt Rd+P450-16(2), ΔMFE+ 
NtRd+P450 clone 1 and ΔMFE+ NtRd+P450 clone 4 strains which were ΔMFE2loop 
outtransformants having Nicotiana Tabacum P450 hydroxylaseandArabidopsis thaliana 
P450 reductase complexexpressed. 
5.3.1 HPLC (High Performance liquid Chromatography) 
High-performance liquid chromatography(HPLC) had been used to check the glucose 
level in the six different strains.Tested strains were been cultured for 120hours and 
336hours on YPD medium with 0.3 % Pelagronic acid as a substrate.Another cultivations 
were made with 1 % Oleic acid with the same strains. 
 
HPLC results of pelagronic acid and oleic acid of three day cultivationsshows that 
there were complete utilization of glucose after 47hours,91hours and 164hours cultivation 
with modified ∆MFE and ΔMFE+ At red+ Nt P450 strains on three day cultiva-
tion.So,based on glucoseconsumption these different time points were been chosen and 
performed with Gas Chromatography-Mass spectrometry. 
 
Cultivations were been repeated at two different temperatures 28°C and 30°C 
fourteen days with both pelagronic acid and oleic acid with all six different strains which 
were mentioned above. At 28° C on 168 hour the ΔMFE+ At red+ Nt P450 strain has 
utilized glucose completely and therefore time points 168 hours, 216 hours and 312 hours 
were been chosen. Whereas at 30° C all glucose were consumed after 72 hours. So 
timepoints 72 hours, 120 hours, 168 hours, 216 hours, 240 hours and 288 hours had been 
chosen. 
 
According to HPLC results from Oleic acid cultivations at 28°C and 30°C glucose 
were completely consumed after 24 hours for ΔMFE4C and ΔMFE+ At red+ Nt P450. 
So time points 24 hours, 72 hours,  120 hours and 192 hours at 28°C had been chosen . 
At 30°C glucose had been utilized completely at 24 hours. So 24 hours , 72 hours, 168 
hours and 192 hours time points were been chosen. 
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5.3.2 Cultivations with pelagronic acid 
Cultivations had been performed in Smit YPD medium at two different temperatures 
(28°C and 30°C) with six different above-mentioned strains. A period of five days culti-
vation and fourteen days cultivations had performed like described above in Materials 
and Methods with 0.3 % pelagronic acid.HPLC were performed to check the utilization 
of glucose and based on consumption of glucose, three different timeperiod had been 
chosen.  
Table: 6. A five days cultivation with 3g/l pelagronic acid at 30°C. 
  STRAIN  
Substrate  ΔMFE4C ΔMFE+ At red+ Nt P450 
 47 h 91 h 164 h 47 h 91 h 164 h 
Nonanoic 
acid(g/l) 
1,75 1,54 0 1,37 0,43 0 
Azelaic 
acid(mg/l) 
0 0 0,68 0 12,05 78,29 
 
Table: 6 Comparison of two different Yarrowia lipolytica  strains (ΔMFE4C and 
ΔMFE+ Nicotiana Tabacum p450hydroxylase + Arabidopsis thaliana P450 reductase 
complex)with 0.3 % pelagronic acid as a substrate and the amount of diacids produced 
at 30°C.Samples were analysed in GC-MS with three different time periods( 
47hours,91hours and 164hours).  
 
 
Figure 28. Cultivations of Yarrowia lipolytica ΔMFE +Nt P450+At Reductase 
(30°C).The substrate (3g/l) were added after 24h to culture grown in Smit-YPD medium. 
Figure shows the utilization of substrate (diamonds) and the amount of azelaic acid 
(squares) produced at three different time points.  
The table below contains results of GC-MS after 14days cultivations at 28°C . The 
substrate used was 3g/l of pelagronic acidwhich were added after 24h cultivation. A com-
parison of three different time points 168h, 216h and 312h had been chosen based on 
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HPLC results. The comparison with six different mutants of Yarrowia lipolytica were 
considered and it shows the ΔMFE+ Nt Rd+P450-1clone utilized substrate completely 
after 216hour and produced 64,08mg/l of diacids after 312hour cultivation.Whereas the 
other strains (wild type, only ΔMFE 1 and ΔMFE 12 strain) didn’t produce any diacids. 
The cytochrome p450 overexpression complex in mutant strains resulted in diacid pro-
duction of different amounts. 
 
Table: 7. A Fourteen Day cultivation with 3g/l pelagronic acid at 28°C 
 Strains                 168h             216h            312h 
 Non-
anoic 
acid 
Azelai
c acid 
Nona-
noic 
acid 
Azela
ic 
acid 
Nonano
ic acid 
Azelaic 
acid 
Yarrowia wild type 0 0 0 0 0 0 
ΔMFE 1 0,83 0 0,75 0 0 0 
ΔMFE 12 0 0 0 0 0 0 
ΔMFE+ Nt Rd+P450-16(1) 0,01 11,28 0 0 0 9,60 
ΔMFE+ Nt Rd+P450-16(2) 0,07 32,01 0 14,11 0 86,32 
ΔMFE+ NtRd+P450 clone 1 0,01 32,63 0 47,44 0 64,08 
ΔMFE+ NtRd+P450 clone 4 0 16,12 0 52,80 0 0 
 
 
Figure: 29.Cultivations of Yarrowia lipolytica ΔMFE +Nt P450+At Reductase clone 1 
(28°C).The substrate (3g/l) was added after 24h to culture grown in YPD medium. Figure 
shows the utilization of substrate (diamonds) and the amount of Azelaic acid (squares) 
produced at three different time points.  
The Table 9 explains the 14-day cultivations at 30°C with substrate 3g/l of 
pelagronic acid, which were added after 24h cultivation. Six different time points had 
been chosen (72h, 120h, 168h, 216h, 240h and 288h) based on glucose utilization accord-
ing to HPLC results. According to this table at 30°C a ΔMFE+ NtRd+P450 clone 1 uti-
lized complete substrate after 168hour and produced 70,747mg/l of C9 diacids at 216hour 
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cultivation.There had a drop in diacids production at 240hour whereas at 30° ΔMFE+ 
NtRd+P450 clone 16 was been able to produce 64,733mg/l. 
 
Table 8. 14 Day cultivation with 3g/l pelagronic acid at 30°C 
  Pelagronic acid(g/l)  
 Strains 
72h 120h 168h 216h 240h 
288
h 
Yarrowia wild type 0 0 0 0 0 0 
ΔMFE 1 1,81 1,53 0,31 0 0 0 
ΔMFE 12 1,43 1,80 0 0 0 0 
ΔMFE+ Nt Rd+P450-16(1) 1,49 0,92 0 0 0 0 
ΔMFE+ Nt Rd+P450-16(2) 1,57 0,619 0 0 0 0 
ΔMFE+ NtRd+P450 clone 1 1,42 0,88 0 0 0 0 
ΔMFE+ NtRd+P450 clone 4 1,58 1,12 0 0 0 0 
 
Table 9. A 14 Day cultivation with 3g/l Azealic acid at 30°C 
  Azelaic acid(mg/l)  
 Strains 72h 120h 168h 216h 240h 288h 
Yarrowia wild type 1,36 0 0 0 0 1,66 
ΔMFE 1 0,34 2,33 6,47 0 4,57 0 
ΔMFE 12 8,90 0 0 0 0 0 
ΔMFE+ Nt Rd+P450-16(1) 9,05 25,75 37,57 17,49 64,73 21,08 
ΔMFE+ Nt Rd+P450-16(2) 0 36,03 59,77 47,37 45,72 36,10 
ΔMFE+ NtRd+P450 clone 1 12,48 27,54 52,49 70,74 68,16 11,88 
ΔMFE+ NtRd+P450 clone 4 0 21,31 30,03 16,47 16,89 0 
 
 
Figure: 30. The production of Azelaic acid (mg/l) by using pelagronic acid (g/l) as a 
substrate with ΔMFE +Nt P450+At Reductase strain. Comparisons of diacid with six 
different time points were taken. An Azelaic acid production at 30°C were been plotted. 
Pelagronic acid (g/l) (diamonds) Versus Azelaic acid (mg/l) (squares) was drawn at 
30°C. 
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5.3.3 Cultivations with oleic acid (C18:1) 
Cultivations had been performed with seven different mutants of Yarrowia lipolytica in 
YPD medium at two different temperatures 28°C and 30°C. A period of five days culti-
vations and fourteen days cultivations had been performed with 10g/l oleic acid. Substrate 
were been added after 24hours to culture and cultivated with 250rpm shaking.HPLC were 
performed to check the utilization of glucose and based on consumption of glucose at 
three different time points had been chosen. 
Table 10.Comparison of two different strains of Yarrowia lipolytica  ΔMFE4C 
andΔMFE+ Nicotiana Tabacum p450+ At Reductase clone 16  with 1 % oleic acid as a 
substrate. Samples were analysed in GC-MS with three different time points 47hours, 
91hours and 164hours. 
  STRAIN  
Substrate  ΔMFE4C ΔMFE+ At red+ Nt P450 
 47 h 91 h 164 h 47 h 91 h 164 h 
Oleic acid 3,40 1,34 0,18 4,77 0,07 0,06 
Di acid 0 0 0 0 0 0 
 
 
Figure: 31. Comparison of two different strains of Yarrowia lipolytica ΔMFE4C 
andΔMFE+ Nicotiana Tabacum p450+ At Reductase clone 16 with 1 % oleic acid as a 
substrate. Samples were analysed in GC-MS with three different time points 47hours, 
91hours and 164hours. Both the mutants utilized substrate periodically but there is no 
diacids production with both the mutants. Figure shows the utilization of substrate (oleic 
acid) (diamonds) and the amount of diacid (squares) produced at three different time 
points 
The below two tables were taken from GC-MS results where 14days cultivations 
of 1% oleic acid were performed at two different temperatures 28°C and 30°C at 
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250rpm.In this case mutants ΔMFE+ Nt Rd+P450-16(1), ΔMFE+ Nt Rd+P450-16(2) and 
ΔMFE+ Nt Rd+P450-clone 1 utilized glucose completely based on HPLC results differ-
ent time periods were been chosen 24hours,72hours,120hours and 192hours at 28°C. At 
30°C the complete utilization of glucose had been seen in 24hours, 72hours, 168 hours 
and 192hours.The same mutants were able to utilize substrate(oleic acid) completely at 
both the temperature’s but there was no diacids production in any of the mutants. 
Table : 11. Fourteen-Day cultivation with 30g/l oleic acid at 28°C. 
 Oleic acid(mg/l)(28°C) 
Strains 24h 72h 120h 192h 
Yarrowia wild type 0,88 0 0 0 
ΔMFE 1 3,85 0.09 0,002 0 
ΔMFE 12 0,44 0,07 0 0 
ΔMFE+ Nt Rd+P450-16(1) 0,02 0 0 0 
ΔMFE+ Nt Rd+P450-16(2) 0 0 0 0 
ΔMFE+ NtRd+P450 clone 1 0 0 0 0 
ΔMFE+ NtRd+P450 clone 4 0,65 0 0 0 
 
In 30°C temperature, no mutant of Yarrowia lipolytica used glucose completely 
at 24hours and no complete utilization of substrate. But at 72hour point there was been a 
complete utilization of oleic acid by all clones of ΔMFE+ Nt Rd+P450 complex. This 
shows that there is a complete utilization of substrate by all strains at 168hours but there 
is no diacids formation in mutants. 
Table: 12. Fourteen Day cultivation with 30g/l oleic acid at 30°C. 
 Oleic acid(mg/l)(30°C) 
Strains 24h 72h 168h 192h 
Yarrowia wild type 0,85 0,19 0 0 
ΔMFE 1 2,83 0,07 0 0 
ΔMFE 12 2,11 0,00 0 0 
ΔMFE+ Nt Rd+P450-16(1) 2,75 0 0 0 
ΔMFE+ Nt Rd+P450-16(2) 2,78 0 0 0 
ΔMFE+ NtRd+P450 clone 1 3,06 0 0 0 
ΔMFE+ NtRd+P450 clone 4 2,74 0 0 0 
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5.4 Pichia guilliermondii 
The below table shows, the plasmids constructed in this work:  
Table: 13. The Table includes Bacterial strains: 
Name Plasmid name Backbone Cloning sites selection E.coli strain 
pBC8 pBluescript_Pg_ARS pBluescript SK- ApaI Ampicillin DH5α 
pBC6 pBlue_Pg_Cre pBluescript SK- EcoRI/SacI Ampicillin DH5α 
pBC50 pBlue_ARS_Hph pBluescript SK- Gibson assembly Ampicillin DH5α 
5.4.1 ARS plasmid (pBC8) 
ARS sequence were been amplified by using BC3/ BC4 oligo pair from Pichia guillier-
mondii strain.These primers were designed based on published ARS sequence available 
with ApaI restriction sites. Genomic DNA of Pichia guilliermondiiC-72064 strain was 
used to amplify ARS sequence.A gel check had been performed to confirm the PCR prod-
uct. All PCR fragments contained the right size. The detected  band size is 870 base pairs 
as expected. These were compared with 1kb Gene Ruler DNA ladder. Thus the construc-
tion of plasmids were successful and confirmed by sequencing. 
 
Figure 32.The above gel picture explains the ARS sequence confirmation and Ladder 
was on both the sides of a gel.Lane1-Lane31 contains amplified products of Pichia 
guilliermondii and expected band is 870bp.  
5.4.2 CRE plasmid (pBC6) 
CRE cassettes had been cloned into pBluescript (SK-). The Colony PCR check were per-
formed to the selected colonies with M13Forward and BC67primers.M13 forward was 
from the pBluescript and BC67 Pg_Tef1_ promoter_rev1 was from the TEF promoter in 
Cre cassettes.Bands been clearly obtained with 400bp as expected and absence of bands 
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in few lanes showed there was no Cre cassette in plasmid and selected plasmids were 
confirmed by sequencing.  
 
Figure 33. A colony PCR performed gel picture was seen and two L-ladders were placed 
on both the corners of the gel.Lane1-Lane26 has CRE colonies. A clear band of 400bp 
was obtained. Few lanes had just smear and there were no clear bands in few lanes. 
5.4.3 HPH + CRE plasmid 
Hph cassettes from pMA plasmid were tried to clone into pBC6 (pBluescript+Cre) but 
they were not able to cloned.Below gel picture shows the restriction digestion from stets 
and digestion had been performed by EcoRI and XhoI.Expected bands were been 5220bp 
and 2351bp.But there were no expected bands seen in any of colonies. This Restriction 
digestion was repeated more than twelve times and screened approximately 164 colonies. 
But couldn’t find the correct clone. 
 
 
Figure 34.The upper gel and lower gel L indicates ladder on last rows of gel.Lane1-
Lane32 were colonies prepared stets and (pBluescript+Cre+Hph) performed Restriction 
digestion. The expected bands were 5220bp and 2351bp. 
 
5.5 Gibson assembly 
The Gibson assembly had been performed for Pichia guilliermondiiand the method was 
performed according to the protocol given by New England’s. BioLabs Inc.. The below 
gel shows colony PCR in order check the correct plasmids.It had been checked by oligo 
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pair BC67 andBC76.BC67 was from Tef1 promoter from Cre cassette(reverse) and 
BC76- Hph marker (forward). The expected band were 750bp and it showed in lane 2. 
 
Figure 35.In this gel the L indicates ladder.Lane1-Lane4 were transformants that were 
from (pBluescript+Cre+Hph+ARS). The expected bands were been 750bp. 
Another colony PCR check was performed to the same above transformants but 
with different oligo pair: BC73and BC74, BC73 sequence is from Hph marker Eno2 pro-
moter and BC74 was from Hph cassette. The expected bands were as 750bp but since it 
is, a colony PCR all bands were not so clear. However, the plasmids were been given for 
sequencing. 
 
Figure 36.In this gel the L indicates ladder.Lane1-Lane4 were transformants that were 
from (pBluescript+Cre+Hph+ARS). The expected bands were 750bp. 
In order to check the correct transformants,all the above transformants had been 
given for sequencing to GATC biotech (Germany).Sequencing results shows there were 
pBluescript(SK-)+ARS+Hph inserts but there was no Cre recombinase cassette. Though 
the PCR product shows the fragment by sequencing results it was confirmed that there 
were no Cre cassette.   
5.5.1 ARS sequence of Pichia guillermondii 
The Pichia guilliermondii has only one published Autonomously Replicating Sequence 
and it had been compared with pBC8 sequence.Clustal-W were used to perform this com-
parison. 
1- Pichia - This represents published sequence of ARS Pichia guilliermondii strain. 
2- Pichia_78ARS- This represents pBC8 sequence from this work.      
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 The results indicate an alignment score of 99.76.This indicates the sequence in 
pBC8 clone was almost similar to the published sequence.  
 
Table: 14 .Scores table of ARS Pichia guilliermondii 
 
 
Comparison sequence 
 
1_Pichia -------------------------------------GTTGACCAACAAT   13 
78_Pichia ATACGACTCACTATAGGGCGAATTGGGTACCGGGCCCGTTGACCAACAAT   50 
 
                     ************* 
 
1_Pichia  CCCGATAAAATTGCTGCAGTTGAGGGAAGAAACAGAGAGGTCAAGGTAGT   63 
78_Pichia CCCGATAAAATTGCTGCAGTTGAGGGAAGAAACAGAGAGGTCAAGGTAGT  100 
          ************************************************** 
 
1_Pichia  GGAACGGGTGCCTATGGTGCCGTTGGCATGGAGAAGTGAGAATGGAATCA  113 
78_Pichia GGAACGGGTGCCTATGGTGCCGTTGGCATGGAGAAGTGAGAATGGAATCA  150 
          ************************************************** 
 
1_Pichia  AGTCAAAAGAGATAGAGGGCTACTTGAGTGCTAAGATTGAAAGGATGGGG  163 
78_Pichia AGTCAAAAGAGATAGAGGGCTACTTGAGTGCTAAGATTGAAAGGATGGGG  200 
          ************************************************** 
 
1_Pichia  CACTTGCTTGAAAAGCCACTCAAGATATGATAGAAGAGATGAAGTTAAGG  213 
78_Pichia CACTTGCTTGAAAAGCCACTCAAGATATGATAGAAGAGATGAAGTTAAGG  250 
          ************************************************** 
 
1_Pichia  ACTTAAGAAATAAATGATGAATTAAATGACGCAAATGTCACTACTCGATT  263 
78_Pichia ACTTAAGAAATAAATGATGAATTAAATGACGCAAATGTCACTACTCGATT  300 
          ************************************************** 
 
1_Pichia  AGAGAAATAGCTATAATGAAGAATTTTGCATTTCGCAAAATTTAAGATAA  313 
78_Pichia AGAGAAATAGCTATAATGAAGAATTTTGCATTTCGCAAAATTTAAGATAA  350 
          ************************************************** 
 
1_Pichia  ATGCAAAAACTGCAAATTACGAAATATGCATATGATACAAGACAAGAAAA  363 
78_Pichia ATGCAAAAATTGCAAATTACGAAATATGCATATGATACAAGACAAGAAAA  400 
          ********* **************************************** 
 
1_Pichia  GACTACCAAAAGTCTCTCGAGAAGAATACTGGGTAACCTTCATCTCTTGA  413 
78_Pichia GACTACTAAAAGTCTCTCGAGAAGAATACTGGGTAACCTTCATCTCTTGA  450 
          ****** ******************************************* 
 
1_Pichia  TTATGCACTGGGGCTATTCATATGCAGATTCGCACGCCGAGGTGCAGCGT  463 
78_Pichia TTATGCACTGGGGCTATTCATATGCAGATTCGCACGCCGAGGTGCAGCGT  500 
          ************************************************** 
 
1_Pichia  TTAGGCGCGGCTCAACGGAAGCCAACGGCCGCCACAAATTGTCCGGAAAG  513 
78_Pichia TTAGGCGCGGCTCAACGGAAGCCAACGGCCGCCACAAATTGTCCGGAAAG  550 
          ************************************************** 
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1_Pichia  TCGCCGAAACTGATCCACTGGTA---------------------------  536 
78_Pichia TCGCCGAAACTGATCCACTGGTAAACGGAAGCCAACGGCCGCCACAAATT  600 
          ***********************                            
 
1_Pichia  ---------------------------------CCACAGCCCCATAAGAA  553 
78_Pichia GTCCGGAAAGTCGCCGAAACTGATCCACTGGTACCACAGCCCCATAAGAA  650 
                                           ***************** 
 
1_Pichia  CCCCCTTTAATATTAAAAACCGTTCTTCAGCCACTTTTGATCACATTGTT  603 
78_Pichia CCCCCTTTAATATTAAAAACCGTTCTTCAGCCACTTTTGATCACATTGTT  700 
          ************************************************** 
 
1_Pichia  TGCAGCCGCCCGTTGCTGCCATCCAAACACCACGCGTCCCCCGCACCCTT  653 
78_Pichia TGCAGCCGCCCGTTGCTGCCATCCAAACACCACGCGTCCCCCGCACCCTT  750 
          ************************************************** 
 
1_Pichia  TTACGGTGCCCACTGCATTGGAATTTGCATAAAACAGCCTCACGAAGTGG  703 
78_Pichia TTACGGTGCCCACTGCATTGGAATTTGCATAAAACAGCCTCACGAAGTGG  800 
          ************************************************** 
 
1_Pichia  ATTAATTTTTAGAGCACTCAAGTCATCATGCTGCAATCTCTGCATCATGA  753 
78_Pichia ATTAATTTTTAGAGCACTCAAGTCATCATGCTGCAATCTCTGCATCATGA  850 
          ************************************************** 
 
1_Pichia  AATGACTCCCGTTGATACAGGGAACTCAGACCGCAAGCGGCGAAGAGTCA  803 
78_Pichia AATGACTCCCGTTGATACAGGGAACTCAGACCGCAAGCGGCGAAGAGTCA  900 
          ************************************************** 
 
1_Pichia  CAAGAGCGTGTGATGTGTGTCGAC--------  827 
78_Pichia CAAGAGCGTGTGATGTGTGTCGACGGGCCCCC  932 
************************            
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6. DISCUSSION 
Cre recombinase lox-P system containing plasmids had constructed forYarrowia lipolyt-
ica and Pichia guilliermondii yeast strains. Autonomously replicating sequences (ARS), 
a Cre recombinase and Hygromycin marker genes with specific promoters and termina-
tors had been used to construct the plasmid. 
6.1 ARS 
Yarrowia lipolytica ARS with 1300bp sequence had been amplified from C-00365 and 
cloned into pBluescript (SK-). The obtained sequence from thesis work was compared 
with published sequences by using Clustal-W. ARS18 and ARS68 were two published 
sequences that were available for Yarrowia lipolytica. After multiple sequence alignment 
comparision it is clearly observed that the available sequence was similar to ARS18 with 
99.69 similarity. There was a less alignment similarity with ARS68 only 64.56 score sim-
ilarity was seen.From results, it had clearly proved that ARS from thesis work was more 
similar to ARS18 than ARS68. 
 
Pichia guillliermondii ARS sequence with 827bp was amplified from C-72064 genomic 
DNA. A comparision of multiple sequence alignment were performed withpBC8 se-
quence and available published sequence a similarity of 99.76 were obtained. 
6.2 CRE casettes 
Cre cassette contains in addition to codon optimised recombinase genes elongation factor 
1-alpha (TEF1) promoter and Triose phosphate dehydrogenase (Tdh3)terminator.Cre cas-
settes from pMA plasmids had been cloned into pBluescript by EcoRI and SacI sites.Ta-
ble 4 and Table 13 clearly shows the plasmid names and with cloning restriction sites. 
Cre cassttes constructionof Yarrowia lipolytica and Pichia guilliermondii was confirmed 
by Colony PCR and by sequencing. 
6.3 HPH casettes 
Hph casette contains Hph marker gene encoding for Y.lipolytica with two LoxP sites at 
the corners of Enolase 2 (ENO2) promoter and phosphoglyceratekinase (PGK) termina-
tor. 
 
P.guilliermondii (Pg_loxp_EnO2_promoter_loxp_Pgk1_terminator) same as like 
Y.lipolyticawith same promoter and terminator from pMA plasmids had been cloned into 
Cre cassettes + pBluescript of Yarrowia lipolytica and Cre cassettes + pBluescript of 
Pichia guilliermondiiby using EcoRV and XhoI. In this case Yarroiwa lipolytica Hph 
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marker cassettes were able to cloned into Cre casettes + pBluescript but where as for 
Pichia guilliermondii unfortunately couldn’t cloned into Cre casettes + pBluescript. 
Therefore, Gibson assembly was performed to alter this method. 
6.4 Gibson assembly 
Pichia guilliermondii with ARS sequence and Cre recombinase by traditional method was 
successfully constructed but unfortunately Hygromycin marker gene were not able to in-
sert into pBC6 clone. Gibson assembly was a new technique where combination of am-
plified inserts with adjacent insert flanks were used to construct complete plasmid vec-
tor.NEB builder were been used to design primers,inserts were amplified by PCR and 
after Gibson assembly transformed into DH5alpha Bacterial strains  according to protocol 
mentioned in New England Inc., Unfortunately, only pBC50(pBluescript+ARS+Hph) 
clone was constructed. In this technique Cre recombinase had been missing to get com-
plete Pichia guilliermondii plasmid vector for transformation into MFE2 deleted strains. 
6.5 Confirmation of the Nat marker loop out transformant 
A complete plasmid vector of Yarrowia lipolytica(pBC27) had tested by transforming 
into Yarrowia lipolyticaMFE2 blocked strain by using LiAc method.By seeing Figure24, 
it indicates a successful loop out of nourseothricin(400µg/ml) marker from Genomic 
DNA and Cre recombinase plasmid had also looped out. 
6.6 Confirmation of the Nicotiana Tabacum P-450 hydrox-
ylase and Arabidopsis thaliana P450 reductase. 
To enhance the cytochrome P450 complex in ω-oxidation Nicotiana Tabacum P450 hy-
drolase and Arabidopsis thaliana P450 reductase were been expressed in the Yarrowia 
lipolytica MFE2 deleted strain successfully. This was confirmed by the diacid production 
in performed cultivations. 
6.7 Cultivations 
Cultivations were been performed in YPD medium at two different temperatures: 28°C 
and 30°C with six different strains of Yarrowia lipolytica. A period of fivedays cultivation 
and fourteendays cultivation were performed with 0.3 % pelagronic acid and with 1 % 
Oleic acid.  
 
At 28°C of five day cultivations with pelagronic acid 47h,91h and 164h according 
to the table 6 and figure 28says as the substrate was consumed the ΔMFE+ At red+ Nt 
P450-16 clone had been able to produce 78,29mg/l of Azelaic acid. Whereas Smit et.al, 
2005 observed the production of dioic acids in Yarrowia lipolytica, by deleting six POX 
genes, they were been able to accumulate only 18 mg ml-1 dodecanedioic acid by using 
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12-hydroxydodecanoic acid as a substrate. A less amount of Azelaic acids was produced 
byΔMFE+ At red+ Nt P450 clone1 and ΔMFE+ At red+ Nt P450-4 that is 64, 08mg/l and 
53,80mg/l . There was no diacid production in wild type of Yarrowia lipolytica and ∆MFE 
1, ∆MFE12. At 30° Ccultivation’s on 216 hour the azelaic acid produced by ΔMFE+ At 
red+ Nt P450 clone1 and ΔMFE+ At red+ Nt P450-16 was only70mg/l and 47,376mg/l. 
So, by this we can conclude that a good amount of azealic acid was produced at 28° C.  
 
Oleic acid cultivations were also performed at both the 28° C and 30° C tempera-
tures. According to table 10 and figure 31it clearly showed that there was a complete 
utilization of oleic acid (substrate) and unfortunately there were no production of diacid 
at any time point. Where as Fabritius and his colleagues (1996) showed that there was 
formation of less than 5g/l of 3-hydroxyhexadecenedioic acid,1,6-hexanedioic acid,ω-
hydroxy octadecenoic acid and 19.4g/l of hydroxydioic acid at 233hour by using oleic 
acid as a sole carbon source in fed-batch fermentation in candida tropicalis mutants.  
6.8 Comparision with Candia tropicalis 
Hara et.al, 2001 studied Repression of POX 4 gene in Candida tropicalis (strain 
M1210A3) which encodes fatty acyl-CoA oxidase activity and the strain had been able to 
produce 17.6 g/l of Carbon13 diacid when these were compared with absence of plasmid 
it was able to produce 14.4g/l of C13 dicarboxylic acid. In a study with ß-oxidation blocked 
completely and by over expressing of cytochrome P450 ALK1 gene ofCandida tropicalis 
it was able to produce 150g/l of dioic acid by using dodecane and tridecane as a substrate 
at 92hours (H5343 strain) (Picataggio et.al, 1992). 
 
According to Huf, 2011 USA, Germany and Japan have done most of their re-
search on Candida tropicalis and developed strain for producing high yield production of 
dioic acids but they couldnot receive up to the mark. In Europe, they considered Candida 
tropicalis as a pathogenic industrial microorganism and need high level of standards to 
use in industrial purposes. However, Yarrowia lipolytica and S. cerevisiae had been stud-
ied but they couldnot reach the levels of C.tropicalis in diacid production. 
  
Multifunctional enzymes perform the hydration and dehydrogenation step of β-
oxidation pathway in higher eukaryotes. There were two Multi functional enzymes in 
mammals but in yeast only one MFE2 is present and there is no evidence until now for 
the presence of isozymes in fungal species or yeast(Bogaert, et.al, 2009). So, MFE2 were 
targeted in these studies where as there are six POX genes are present so deleting one 
single MFE 2 gene is easier than the other genes. Nevertheless, in recent studies of 
Vorapreedaan interesting result were out by comparing oleaginous yeast and non-oleagi-
nous yeast genomes says in oleaginous microbes in addition to peroxisomal β-oxidation, 
fatty acid degradtaion also occurs in mitochondria. There was an evidence clearly that 
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mitochondrion orthologus targeted proteins which were involved in β-oxidation. Yar-
rowia lipolytica possesees an incomplete set of mitochondrial β-oxidation enzymes acyl 
CoA dehydrogenase, 2-enoyl CoA hydratase and 3-ketoacyl CoA thiolase. By this evi-
dence it’s concluded that fatty acid degradation also occurs in mitochondria. Mitochon-
drial β-oxidation pathway was a type I that involves in breaking down of medium and 
short chain fatty acids. (Voraoreeda, T., et.al, 2012) However, our results showsmall 
amounts of C9 diacid production which was lower than compared to Candida tropicalis. 
From industrial point of view, the amount produced were very less but on the other hand 
the application of C9 diacid is high and production was in sustainable way from genet-
ically engineered micro organisms. This was not as profitable to industry they need to 
produce in larger amounts. However, the results of this work show more bottleneck and 
other limiting factors in engineering Beta Oxidation pathway. By this metabolic engineer-
ing work of this thesis proved that there were production of dicarboxylic acids from al-
kanes and fatty acid in Yarrowia lipolytica. But essential modifications would be needed 
to further study and develop this strain for industrial purpose as it was considered as non-
pathogenic. 
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7. CONCLUSIONS 
Long chain DCA production was demonstrated with yeast Yarrowia lipolytica. Cre re-
combinase plasmid had been constructed successfully. A Successful loop out of nourse-
othricin (400µg/ml) marker from genomic DNA and Cre recombinase plasmid from 
MFE2 deleted Yarrowia lipolytica strain could be observed. Overexpressing the first en-
zymes of ω-oxidation enzyme Nicotiana Tabacum P 450 hydroxylase and Arabidopsis 
thaliana P450 reductase (P450 oxidoreductase) in the Yarrowia lipolyticaMFE2 deleted 
strains were successful. Cultivations with pelagronic acid were been successful and 
78,29mg/l of C9 diacids were produced. Whereas with Oleic acid only substrate con-
sumption was seen: There was no diacid production. 
 
Pichia guilliermondii was constructed by two different methods a traditional 
method and Gibson assembly. A plasmid with two genes of interests was been able to 
construct by Gibson assembly. PBluescript with ARS and Hph were successful by Gibson 
assembly. Whereas in traditional method pBluescript+ARS and pBluescript+Cre was 
constructed .The work on Pichia guilliermondii can be carried further by constructing 
complete plasmid vector. 
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